|
Cerus Endovascular secures
£600,000 for device to treat brain aneurysms
Cerus
Endovascular Ltd has secured investment from The North West Fund for
Biomedical to further develop its implantable medical device for
treating intracranial aneurysms. 21 May 2013
GE Healthcare to supply Kent &
Medway Medical Imaging Consortium with collaborative radiology system
East Kent Hospitals University NHS Foundation Trust has awarded GE
Healthcare a seven-year managed service contract to supply imaging
services to the four hospital trusts of the Kent & Medway Medical
Imaging Consortium. 21 May 2013
Aesica partners with the University of
Nottingham to develop novel amide chemical synthesis techniques
Aesica has announced a partnership to develop alternative
methods of amide bond synthesis for pharmaceutical manufacturing. 21
May 2013
BioCity to develop BioHub at
AstraZeneca's Alderley Park site
BioCity Nottingham Ltd, the
UK’s leading provider of life sciences business incubation services,
has been appointed by AstraZeneca to establish a new centre for
bioscience companies at Alderley Park in Cheshire. 21 May 2013
Hugo Technology sees
year-on-year growth
Despite continuing uncertainty within the
UK economy, medical technology repair and maintenance firm, Hugo
Technology, has continued to grow during 2012.
Recipharm manufacturing site in France
approved by Japanese drug agency
Recipharm’s solid dose
facility located in Fontaine, France, has been approved for supply
of manufactured products to the Japan’s pharmaceuticals market. 19
Apr 2013
AstraZeneca outlines major
restructuring of R&D and strategy to return to growth
AstraZeneca
has announced plans for to establish a new global R&D centre and
corporate headquarters in Cambridge in the UK by 2016. The move is part
of the company’s proposals to create strategic global R&D centres in the
UK, US and Sweden to improve pipeline productivity and to establish it
as a global leader in biopharmaceutical innovation. 4 Apr 2013
InteRNA Technologies secures
additional equity financing for melanoma treatment
Utrecht-based
InteRNA Technologies B.V. has closed an equity financing round, with new
investors including the ‘Innovation & Investment Fund Gelderland’,
managed by PPM Oost and several business angels. 4 Apr 2013
Anglia Ruskin to start
construction of Medical Business Innovation Centre
Construction of the first building of the new Anglia Ruskin
University medtech campus will start at the beginning of April. The
£6 million Medical Business Innovation Centre (MedBIC) will be built
on the Chelmsford campus. 25 Mar 2013
Edgbaston Medical Quarter forms
world class stronghold for medical
technology development
The EMQ, a cluster of medical organisations
and medical technology companies, was officially launched at the Medilink
UK Life Sciences Summit in Birmingham this week. 20 March 2013
Novo Nordisk’s insulin
delivery device approved in China
Novo Nordisk’s latest
device for insulin delivery, NovoPen 5, has been approved by the
Tianjin Food and Drug Administration for launch in China. 20 Mar
2013
Plessey Semiconductors expands
distribution network in Asia
Plessey and Supreme Components Inc
(SCI) have signed a distribution agreement for the Singapore, Thailand,
Malaysia and Vietnam markets. 20 Mar 2013
Diagnostic Healthcare secures £1m
investment to expand services
The company will use the investment
to expand its diagnostic services, increase community services in more
locations across and expand its portfolio of medical equipment. 20 Mar
2013
MTB Europe launches new Marcomms Service for medical technology
vendors
In response to a huge rise in requests and having
established a clear market need, MTB Europe has launched a range of
marketing and communications services for vendors and suppliers in
the medical technology sector. 11 Mar 2013
Anglia Ruskin MedTech Campus
offers gateway to the NHS market
The MedTech Campus is
launching its Business Network Services at the Healthcare Innovation
Expo on 13 March, to give companies the opportunity to access NHS
clinicians, academics, industry and customers. 8 Mar 2013
AstraZeneca and Exco InTouch to
develop chronic disease management software
AstraZeneca and
patient management systems developer Exco InTouch have announced a
programme to develop interactive mobile phone and internet-based
health tools for tracking and managing chronic conditions. 28 Feb
2013
Medtech and life sciences sector
in East Midlands standing up to the recession
Medilink East
Midlands says that the sector has overcome the business support
difficulties posed by significant changes in government policy over
the last three years. 19 Feb 2013
Oxford Nanopore
announces further collaborations for nanopore sensing
technology
The company has completed agreements
with the University of Illinois, Brown University,
Stanford University, Boston University, University of
Cambridge and the University of Southampton. 13 Feb 2013
Curie-Cancer and GenoSplice
Technology in genomics informatics partnership
Curie-Cancer, part of Institut
Curie, and GenoSplice Technology have formed a partnership to combine their
expertise in genomics to develop new cancer treatments. 13 Feb 2013
Big pharma companies
facing US$100bn shortfall in growth due to flat sales
The largest pharmaceutical companies are facing a
widening growth gap that will increase pressure to drive
growth through mergers and acquisitions (M&A) to bridge
the gap. 7 Feb 2013
NHS leasing wider range of
medical equipment, according to SFS research
Leasing in the
NHS is growing in popularity and extending to a wider range of
equipment, according to a new analysis by Siemens Financial Services
(SFS) of leasing activity in 2012. 4 Feb 2012
Bone Therapeutics raises €7.7m to
fund bone cell therapy pipeline
The company has successfully
closed a Series D funding round, raising €7.7m from current
investors and the Walloon Region of Belgium. 30 Jan 2013
Philips and
University of Malaya to establish centre for sleep disorders
South East Asia’s first excellence centre for sleep disorders will be
established at the University of Malaya Specialist Centre (UMSC) in
collaboration with Philips Malaysia. 23 Jan 2013
Rosetta Capital
buys SEK220 million share in Karolinska Development holdings
Karolinska Development AB
has announced that a syndicate led by
the life science investor Rosetta Capital will
acquire a minority share in Karolinska Development’s holdings in 13
of its 25 portfolio companies for SEK 220 million. 21 Dec 2012
NanoKTN urges UK
SMEs to take advantage of £10m R&D funding call
UKTI is calling
for innovative proposals from SMEs that focus on projects that advance
the development of a recent technological discovery or breakthrough in
the context of significant and identifiable technological risk. 4 Dec
2012
Endomagnetics
selected as high-potential company by Future 50 Project
Endomagnetics is developing nanomagnetic technology as an alternative to
the radioisotopes currently used for tracking the spread of cancer. 30
Nov 2012
North West Fund for
Biomedical invests £400,000 in local medtech companies
This is
the third tranche of funding for both companies, which received initial
Pathfinder investments in 2011 and further development funds earlier
this year. 23 Nov 2012
UK Business
Secretary announces a few more peanuts invested in tech sector
The Technology Strategy Board will invest up to a further £6 million in
new Launchpad competitions to accelerate the development of existing
clusters of innovative high growth SMEs around the UK. 21 Nov 2012
QuantuMDx acquires
identity testing services company Northgene
The acquisition
will provide funds to further develop NorthGene’s laboratory and
staffing infrastructure, secure various laboratory accreditations
and to expand the Company’s test portfolio and DNA analysis
services. 14 Nov 2012
Hand-held device can diagnose flu virus
strains in minutes
Newcastle-based OJ-Bio has secured funds
to further develop a device for the rapid, simple and low cost
diagnosis of flu and other viruses. 13 Nov 2012
phenox receives CE Mark approval for
brain embolisation device
The phenox p64 flow modulation
device is an intraluminal flow diverter intended to treat complex
intracranial aneurysms and dissections. 6 November 2012
Zilico secures further £750K funding
for cervical cancer test
Zilico Ltd has secured £750K
investment from The North West Fund for BioMedical. This follows £1m
investment announced in June 2012. 6 Nov 2012
UK government to invest £7m to promote additive manufacturing
Grants for collaborative R&D projects in additive manufacturing,
also known as 3D printing, will be awarded through an open
competition. 26 Oct 2012
Record year heralds
expansion for Raleigh Coatings
Staffordshire-based Raleigh
Coatings is looking to create skilled jobs at a new production facility
following a record year for sales and turnover. 26 Oct 2012
Manchester United appoints Toshiba
as official supplier of medical systems
Toshiba Medical Systems
will provide state-of-the-art medical equipment to a new medical centre
at the club’s training ground. 26 Oct 2012
More collaboration
between business and universities needed to boost UK economy
UCB has called on the UK Government to ensure that measures to
strengthen partnerships between universities, business and the NHS
actually deliver results. 24 Oct 2012
Flaws in EU
regulation of medical devices, says BMJ
A joint undercover
investigation by the BMJ and the Daily Telegraph has
exposed flaws in the EU system used to grant market access for devices
such as replacement hips, cardiac defibrillators, and breast implants.
24 Oct 2012
European medtech associations form
new alliance to drive industry forward
Eucomed and EDMA, the
European Diagnostic Manufacturers Association, have formally launched a
new alliance called MedTech Europe. 10 October 2012
Select Bio Laboratories
moves into BioCity Scotland
Lanarkshire-based biosciences
incubator, BioCity Scotland, has signed a deal with the Select
Pharma Group to move its contract testing laboratory services onto
the site this month. 9 Oct 2012
Boston Scientific to acquire
Rhythmia Medical
Rhythmia Medical, Inc. is a developer of mapping
and navigation solutions for use in cardiac catheter ablations and other
electrophysiology procedures, including atrial fibrillation and atrial
flutter. 9 Oct 2012
ABHI launches website to
promote UK medtech exporters at trade fairs
ABHI
International has launched ABHI UK Pavilion to promote UK medical
technology manufacturers and help SMEs gain access to foreign
markets. 26 Sept 2012.
St Jude mini neurostimulator to treat chronic migraine gains EU
approval
The Eon and Genesis systems deliver peripheral nerve
stimulation (PNS) of the occipital nerves to manage the pain and
disability associated with intractable chronic migraine. 21 Sept 2012
ASEAN Medical Device Directive to
give US$400m boost to market
A new co-operation agreement between
10 South East Asia countries to standardize medical device registration
will allow suppliers to take advantage of more than $400M of new
emerging business in four key areas. 21 Sept 2012
Boston Scientific
expands cardiology portfolio with acquisition of BridgePoint Medical
BridgePoint Medical is a privately held company that has developed a
catheter-based system to treat coronary chronic total occlusions
(CTOs). 20 Sept 2012
Case study: Finesse
Medical streamlines processes with business management solution. 17
Sept 2012
Sygnature Discovery
strengthens management team
Nottingham-based Sygnature
Discovery Limited appointed Colin Sambrook Smith to the
newly-created role of Head of Computational Chemistry and
Informatics. 4 Sept 2012
British Business Embassy summit on
assistive technology heads to birthplace of Paralympics
A unique
business summit hosted today by UKTI presents the UK’s excellence in
assistive medical technologies to international business leaders. The
group will spend part of the day in Stoke Mandeville Hospital, the
birthplace of the Paralympics. 3 Sept 2012
German medical
technology sector increases revenues to €21.4bn
BVMed, the
German medical technology association, has reported that the total
revenue of medical technology companies in Germany increased by 6.9%
to €21.4bn in 2011, with exports increasing over 10%. 31 Aug 2012
BioCity Scotland appoints new
board member
BioCity Scotland, the centre for life science
businesses in Newhouse, Lanarkshire has announced the appointment of Dr
Allison Jeynes-Ellis as a new Board member.
Technology Strategy
Board outlines £250m investment in UK business growth
The
Technology Strategy Board has outlined how up to £250m will be
invested in 60 competitions for funds designed to stimulate business
growth. 23 July 2012
DNA Electronics to present at UKTI’s Healthcare and Life
Sciences Summit
The Summit is hosted by UK Trade & Investment (UKTI) as part of the
business events around the London Olympic games. 25 July 2012
Cellular Systems awarded TSB/ DEFRA research grants
Nottingham BioCity-based Cellular Systems has been awarded
grants for a poultry disease detection system and egg shell waste
product development. 18 July 2012
Calixar and Synthelis
partner to provide membrane protein services
Two French
companies specialising in membrane proteins, Calixar and Synthelis,
have entered into an alliance for the production and isolation of
all types of target membrane proteins. 17 July 2012
EyeBrain researchers move into
Brain and Spine Institute
The aim is to foster scientific
exchange with ICM researchers and speed up the development of
clinical research tools for neurological diseases. 16 July 2012
Places in US trade mission offered to
medtech SMEs
Twenty companies will be chosen to travel to
Boston, Massachusetts to take part in the Future Health Mission 2012
at the end of September. 3 July 2012
Johnson & Johnson completes $20bn
takeover of Synthes
Synthes has been integrated with the
DePuy franchise to establish the DePuy Synthes Companies of Johnson
& Johnson. 19 June 2012
TLT appoints Dr Art Tucker as
Clinical Director
Dr Tucker is a Principal Clinical
Scientist and Vascular Researcher at St Bartholomew’s Hospital,
London; Honorary Reader at The William Harvey Research Institute,
Queen Mary University of London. 18 June 2012
Calixar secures €875K funding
round to develop membrane protein services
The funds will
enable Lyons-based Calixar to develop its international operations
for membrane protein services and move its research programs
forward. 18 June 2012
UK government funds 16 R&D
projects for hi-tech manufacturing
The UK Technology Strategy
Board and the Engineering and Physical Sciences Research Council are
to provide £6.5 million grant funding to support the development of
new technologies in manufacturing. 15 June 2012
Boston Scientific completes
acquisition of Cameron Health
The acquisition of San
Clemente-based Cameron Health, Inc adds the company's subcutaneous
implantable cardioverter defibrillator, the S-ICD System, to Boston
Scientific's portfolio. 11 June 2012
TSB awards £1m funding to
develop small molecule drug platform
Three companies,
Isogenica, Biolauncher, and Cresset Group, have been awarded £1m
funding from the UK Technology Strategy Board to develop a
highly-scalable approach to small molecule drug discovery. 7 June
2012
Abbott awarded CE mark for
PLEX-ID rapid microbial identification system and clinical tests
PLEX-ID, which is based on molecular diagnostic technologies,
addresses a significant unmet need for rapid detection and
identification of a broad range of microbes that cause infections in
patients. 28 May 2012
Idaho Technology receives FDA 510(k)
clearance for rapid respiratory pathogen detection system
Idaho Technology, Inc. has announced US FDA 510(k) clearance of five
additional pathogens for its FilmArray RP system and the launch in
European markets. 28 May 2012
UK medtech sector
boosted by launch of Anglia Ruskin MedTech Campus
The Anglia
Ruskin MedTech Campus will provide one of the world’s largest health
innovation spaces, with the aim of establishing the UK as a global
force in the sector. 22 May 2012
Sygnature Discovery and
Pneumolabs partner in drug development services
The companies
have entered into a strategic alliance to provide a fully-integrated
drug discovery service to accelerate clients’ drug discovery
programmes into development. 17 May 2012
Conference on funding
innovation in biotech and medtech
This event, on 13 June
2012, will help identify the best routes to accessing funding
programmes that match project needs. 14 May 2012
Manchester university
spin-out turns into world leading quantum dot producer
Quantum dot producer Nanoco has grown from a university spin-out to
one of the UK’s most significant nanotechnology companies. 8 May
2012
Click on the arrows
above to see more products
Seminar in Birmingham on
market for devices for diabetics
Commercial opportunities to
develop new devices for diabetics will be showcased in the first of
a series of events by medtech industry specialist Medilink. 6 May
2012
German medtech sector
driving innovation and exports
Nearly 50% of German medical
technology companies are expecting increased profits this year and
the healthcare sector has higher revenues than the automotive
sector, at €278bn. 30 Apr 2012
DiaGenic and GE
Healthcare to develop blood-based test for early Alzheimer's
The blood-based test will use DiaGenic’s peripheral gene expression
profiling in patients with mild cognitive impairment, a disorder
associated with risk for Alzheimer’s Disease. 30 Apr 2012
Memorial
Sloan-Kettering Cancer Center and IBM collaborate to develop oncology
decision support with IBM Watson
The tool, built upon IBM Watson,
will provide medical professionals with improved access to current and
comprehensive cancer data and practices. 30 Apr 2012
Celtic Therapeutics
invests $50M in developing antibody drug conjugates
A new company
will be based in Switzerland to develop, ADCs (developed in London!)
which are fast becoming the most exciting new class of oncology drugs as
they combine the specificity of antibodies with the cytotoxic power of
novel “warhead” chemistries. 30 Apr 2012.
Elekta wins Queens Award
for export performance
Stockholm-headquartered Elekta, has
received the Queen's Award for Enterprise 2012 in the International
Trade category for the performance of its Crawley, UK plant. 25 Apr
2012
Immunodiagnostic Systems Holdings
receives Queens Award for Enterprise
More than 90% of IDS’
products are exported internationally and the Company has continually
grown its export revenues and profits over the last six years. 25 April
2012
Isansys Lifecare
achieves CE Mark for LifeTouch Patient Surveillance System
The LifeTouch is a cloud-ready medical device, and the first to
be certified as a Class IIa medical device under the European
Medical Device Directive (MDD). 18 Apr 2012
Westhouse Medical
Services acquires glaucoma treatment from Sunridge International
Westhouse Medical Services Plc. has entered into a US$2m cash and
bond deal to acquire the patents, manufacturing rights, distribution
agreements and intellectual property for Pneumatic Trabeculoplasty. 18
Apr 2012
UK government to open
£180m funding to support biotech and medtech companies
The
Biomedical Catalyst fund for innovative SMEs and academia to develop
solutions to healthcare challenges will open for applications at the
end of April. 14 Apr 2012
New guide to procurement in the NHS
The complex routes
to NHS procurement are mapped out in a new publication, The NHS Procurement Guide,
published quarterly by Medilink UK. 3 Apr 2012
BioCity Scotland
offers £10,000 Dragon's Den prize for entrepreneur boot campers
The Boot Camp is a three-day intensive business development programme
designed to prepare scientists to be their own boss. 3 Apr 2012
Promethera
Biosciences raises €23.6m series-B financing
Among the new
investors are the venture arms of pharmaceutical industry leaders
Boehringer Ingelheim and Shire, Japanese investment fund Mitsui
Global Investment, US company ATMI and Belgian venture capital fund
Sambrinvest. 28 Mar 2012
Enterome raises €5m series A
funding
This funding follows a previous seed round that raised
€1.5 million from Seventure Partners (Natixis) and INRA Transfert. It
will allow further development of biomarkers for abnormal flora of the
human intestine. 28 Mar 2012
Eucomed launches European medtech
conference vetting system
The independent Compliance Panel of
Eucomed has launched the system to review third-party educational
conferences for compliance with ethical practices. 28 Mar 2012
Stevenage BioScience Catalyst
and Kurma Life Sciences Partners collaborate to boost investment in
UK bioscience
The parties will work together and
independently on sourcing investments based on innovative science,
from both academia and the pharmaceutical industry. 26 Mar 2012
Domain Therapeutics wins €933,000
grant for schizophrenia drug project
Domain Therapeutics has announced that the ATHOS project has
been selected for French government funding. 22 Mar 2012
Michelson Diagnostics
secures £600k investment for further growth
Michelson
Diagnostics has announced a further investment of £607k by
shareholders Octopus Investments, Catapult Venture Managers and
London Business Angels. 22 Mar 2012
Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in
Biosurgery
Siemens announces successful completion of bid for RuggedCom Inc.
Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron
Chelator Treatment
Boston Scientific to Acquire Cameron Health, Inc.
Mobius Life
Sciences Fund invests in XenoGesis Limited
XenoGesis Limited
is a contract research organisation (CRO) set up by ex-AstraZeneca
researchers. The financing is part of a £135,000 investment round.
12 Mar 2012
BioCity Nottingham
appoints life sciences industry leader Dr John Brown to board
Dr
Brown's arrival closely follows the launch of BioCity Scotland, and
marks another step-change in the growth ambitions of the company.
NanoKTN announces
success of Plessey EPIC sensor resulting from TSB funding
Through
support offered by the NanoKTN and JEMI UK, Plessey Semiconductors has
been able to promote its product to potential end-users, vital in the
early stages of the product’s marketing. 12 Mar 2012
Helios BioSciences
becomes 27th company to move into Biocitech technology park
Biocitech, the Paris life sciences technology park, has announced the
arrival of Helios BioSciences, a provider of bioinformatics services in
support of the drug discovery process. 9 Mar 2012
Boston Scientific
to acquire Cameron Health for initial US$300m
California-based
Cameron Healthhas developed a subcutaneous implantable cardioverter
defibrillator — the S-ICD System. 8 Mar 2012
BioCity Scotland
signs up first business partner
BioCity Scotland, the
newly-opened life sciences cluster in Newhouse, Lanarkshire, has signed
a three-year agreement with leading patent attorneys HGF making them the
first corporate partner to join the BioCity team. 29 Feb 2012
Integromics
partners with FPGMX to develop low-cost methods for clinical genomics
Integromics has entered into a partnership with the Galician
Foundation of Genomic Medicine for the development of inexpensive
solutions for clinical genomics. 29 Feb 2012
Endomagnetics wins
ACES award for most successful university spinout
Endomagnetics
is developing advanced magnetic sensing technology for use in breast
cancer staging, based on technology developed between University College
London and at the University of Houston. 23 Feb 2012
Feature: Medtech industry will start to change the delivery of its
communications in 2012
Tristan Jervis,
Director at De Facto Communications, explains how the
medtech industry, not unlike the pharma industry of 10 years ago, is
in the midst of a gradual reform of its modus operandi
to accommodate a changing economic model and cultural shift bringing
innovation closer to the patient. 22 Feb 2012
EOS Imagine
raises over €38m on NYSE
NBGI Ventures has announced that its
portfolio company EOS Imagine, has raised over €38 million in a
successful public offering of shares on the NYSE Euronext. 20 Feb
2012
UCL spinout takes nano-enabled
pain therapy to international markets
Support by the UK NanoKTN
has helped UCL School of Pharmacy spin-out Nanomerics to take its
patented nano-enabled therapeutic technology to international markets.
20 Feb 2012
NHS interest in financing
techniques to purchase medical equipment soars
New research from
Siemens Financial Services (SFS) has revealed steeply rising interest in
leasing in the NHS. The research tracked the number and the value of
leasing tenders issued by the NHS. 20 Feb 2012
Sanofi: 2011 Results Benefit from Genzyme Acquisition
Syngenta CEO Announces Record Free Cashflow at Full-Year Results
Gerresheimer Achieves High Growth in the 2011 Financial Year
Siemens Forms New Companion Diagnostics Partnerships with ViiV
Healthcare and Tocagen
Pepscan Therapeutics Achieves Milestones in Research Collaboration
With Janssen R&D Ireland
Southern Scientific moves to
Henfield
The move follows the purchase of Southern
Scientific in September 2011 by LabLogic Systems. 6 Feb 2012
GE healthymagination Fund invests
in Check-Cap's ingestible imaging capsule
GE Financial Services
has announced that it has invested in Israeli company Check-Cap Ltd, a
developer of an ingestible X-ray imaging capsule that may help detect
intestinal polyps and colorectal cancer. 6 Feb 2012
AstraZeneca announces 2,200 R&D job
cuts worldwide
AstraZeneca has announced a set of new
restructuring initiatives along with its full-year 2011 results
today. The programme is expected to lead to 7,300 job losses in
total, with 2,200 of those R&D and save $1.6bn annually. 2 Feb 2012
Liverpool universities and hospitals
to build 2 million sq ft BioInnovation Centre
The Liverpool
BioInnovation Centre is a 2 million square foot project that aims to
create up to 5000 high tech jobs and make Liverpool a world class
centre of innovation in the life sciences. 2 Feb 2012
Endomagnetics wins CE Approval
for Sienna+ Tracer for breast cancer care
The injectable
tracer is used in combination with the ultra-sensitive SentiMag
instrument in sentinel lymph node biopsy (SLNB), currently the
standard of care in tracking the spread of breast cancer. 19 Jan
2012
BerGenBio completes $9m
financing for anti-tumour compound development
The financing will
be used primarily to take lead compound BGB324 into clinical trials
and to develop a companion diagnostic. 19 Jan 2012
MindFrame awarded
third patent for Capture LP thrombectomy technology
The
company's technology is used to treat ischemic stroke therapy, in
which rapid flow restoration and clot retrieval is essential to
prevent irreversible deterioration of brain function. 19 Jan 2012
EDMA and Eucomed join forces
to create European industry federation
The move aims to
enhance the recognition of their joint membership at European level
and make them uniquely positioned to address common issues of
interest. 17 Jan 2012
St Jude Medical to expand Plymouth, USA
campus for Cardiovascular Division
The building will
consolidate the company’s current Cardiovascular Division leased
locations in Minnetonka and Maple Grove with existing operations at
the site. 17 Jan 2012
Midatech
secures £6.3m financing for nanomedicine product development
The financing will be used to support clinical development of
chemotherapeutic gold nanoparticles designed to target ovarian, lung
and breast carcinoma. 17 Jan 2012
Plasticell wins
£750k TSB funding for £1.5m stem cell manufacturing project
Plasticell has announced that the Technology Strategy Board has
invested in the Company’s CombiCult, the high throughput technology
for stem cell research and development. 13 Jan 2012
Sygnature Discovery's new
bioscience group fully operational
Sygnature Discovery has
announced that its new Bioscience group is already involved in a
number of drug discovery activities for clients, including
integrated discovery projects and in vitro biology-only projects. 5
Jan 2012
One Nucleus signs agreement with SEHTA for members' access to
preferred suppliers
One Nucleus has signed an agreement with SEHTA (South East
Health Technologies Alliance) that gives SEHTA members access to One
Nucleus Preferred Suppliers through the One Nucleus Purchasing
Consortium Scheme. 5 Jan 2012
SEHTA adopts new
business model to ensure support for medtech sector
The South
East Health Technologies Alliance is to adopt a new business model
to enable it to continue to assist its existing members, new members
and other organisations. 5 Jan 2012
Artificial skin-making
technology for sale following collapse of developer
The Ideas
Studio, which has gone into liquidation, developed an automated
manufacturing process for Smart Matrix, an artificial skin product
owned by the Restoration of Appearance and Function Trust. 18 Dec
2011
Alliance Medical unveils new strategy
The company has developed a new strategic vision focusing on its
belief in the importance of “intelligent imaging”. 18 Dec 2011
EIB, EIF and EC launch
facility to help technology-based SMEs get loans for RDI
The new risk-sharing instrument for SMEs will be managed by the EIF.
In addition, the EIB and the European Commission are to provide
extra resources for research infrastructures. Read more to find out
what all the acronyms stand for ... 12 Dec 2012
UK Future Technologies Fund backs SEP IV to support high technology businesses
The UK Future Technologies Fund has committed to SEP IV, the
latest fund managed by Scottish Equity Partners continuing the
support of the European Investment Fund. 12 Dec 2012
Systagenix Wound
Management adds two directors to board
Systagenix Wound
Management has announced the appointments of Oern Stuge, CEO of
ORSCO Life Sciences AG,. and Jack Wilkens, EO of RevDia, as members
of the company’s Board of Directors. 3 Dec 2011
Systagenix Wound
Management adds two directors to board
Systagenix Wound
Management has announced the appointments of Oern Stuge, CEO of
ORSCO Life Sciences AG,. and Jack Wilkens, EO of RevDia, as members
of the company’s Board of Directors. 3 Dec 2011
US and Asia show strong demand
for German medical technologies
Demand for German medical
technologies will grow by 6% percent in 2011, according to industry
experts, with above average demand from the USA and Asia. 28 Nov
2011
Michelson Diagnostics
shareholders invest £1.9m to expand sales of skin cancer scanner
Michelson Diagnostics has announced an investment of £1.912 million
by shareholders Octopus Investments, Catapult Venture Managers and
individual investors from London Business Angels. 28 Nov 2011
Leica
Microsystems acquires Labindia’s Microscopy and Histopathology
Divisions
Labindia Instruments Pvt. Ltd. is a leading solutions and service
provider in India that has successfully distributed Leica’s products
in India for over 20 years. 28 Nov 2011
Sphere Medical
floated on AIM
Sphere Medical Holding plc has announced
trading of 18,943,843 additional Ordinary Shares on 18 November on
AIM, following First Admission of 17,861,801 Ordinary Shares on 17
November 2011. 23 Nov 2011.
NanoKTN offers advice for
applying for £27m Technology Strategy Board funds
The UK
Nanotechnology Knowledge Transfer Network (NanoKTN) is encouraging
its members to apply for a share of £27 million made available by
the Technology Strategy Board for grants for innovative research and
development projects. 22 November 2011
Endomagnetics
raises additional funding for novel cancer diagnostics probe
Cambridge-based Endomagnetics has raised funding totalling £1.8
million. The Company has also announced a move to Cambridge and two
new appointments as it expands its operations. 23 November 2011
BioCity Nottingham attracts ex
AstraZeneca and Pfizer entrepreneurs
Six new companies
started by former AstraZeneca Charnwood employees will create 15
jobs within BioCity Nottingham by the end of November, 23
November 2011
MEDICA and COMPAMED driving
jobs in the med tech sector
At this years events 4,571
exhibitors presented the entire cross-section of new products,
services and processes for increasing efficiency and quality for in
and out-patient care to 134,500 visitors. 23 Nov 2011
Smart Solutions winners chosen
by North West NHS Innovation Service
Medical experts in
Liverpool, Tameside and Warrington are to play a key role in testing
three new medical devices chosen as winners of the Smart Solutions
for Healthcare competition. 20 Nov 2011
Domainex awarded TSB funding
to develop kinase-inhibiting anti cancer drug
Domainex has
been awarded a £250,000 grant by the TSB to support the development
of a new drug for the treatment of several common cancers. 20 Nov
2011
Record number of exhibitors at
Medica 2011
From 16-19 November 2011, the attention of health
and medical professionals from around the world will once again
focus on Düsseldorf, as the world's largest medical trade fair,
MEDICA 2011, World Forum for Medicine, and COMPAMED 2011 get
underway. 15 Nov 2011
Rhône-Alpes region's health
sector strongly represented at Medica 2011
The Medical
Technology Cluster in Saint-Etienne and the I-Care Cluster in Lyons
will attend, together with a number of their members. 15 Nov 2011
UK med tech
companies lead export push
Companies from across the UK are
putting their medical technology products on the international trade
map this week when they exhibit at MEDICA. 15 Nov 2011
Cobra Biologics
acquires Unitech Pharma Group
The facility in Matfors will
bring over 20 years of bio-production experience to Cobra, with
their offering complimenting Cobra’s existing expertise and
capacity.
Sygnature
Discovery and Saretius in strategic alliance for drug discovery
The companies will collaborate to provide a fully-integrated drug
discovery service to accelerate clients’ drug discovery programmes
into development. 11 Nov 2011
Medical
technology innovations from 75 UK companies on display at Medica
2011
The Association of British Healthcare Industries is once
again organising the UK Pavilion at MEDICA (Hall 16 Stand G10-3),
housing 75 of the UK’s most innovative med-tech companies.
Microsulis
microwave ablation sytem approved to show ETL safety mark
This accreditation mark will now appear on Microsulis Medical’s
Sulis VpMTA Generator, which powers the Acculis range of microwave
tissue ablation devices. 7 Nov 2011
Almac invests £1m in mass
spectrometry facilities for analytics services
Almac's new
£1m facility at its northern Ireland headquarters houses
state-of-the-art mass spectrometers and underlines Almac’s
commitment to providing the best analytical facilities for its
customers. 23 Oct 2011
QuantumDX licenses
nanostructures for DNA sequencing in hand-held devices
Newcastle-based QuantuMDx Group Limited has signed an exclusive
license agreement with US nanotechnology developer Nanosys Inc for
several patents and patent applications related to the use of
nanostructures for biosensors. 23 October 2011
GE announces $100m innovation
challenge and $1bn R&D investment in cancer care
GE has
launched a new healthymagination initiative to accelerate cancer
innovation and improve care and announced a US$100 million global
open innovation challenge for breast cancer diagnostics. 2 Oct 2011
Loxbridge in $7m joint venture with Dr Kary Mullis
to develop novel therapeutics
The new company, Altermune
Technologies LLC, will focus on the development of novel
therapeutics to combat resistant pathogens such as MRSA, C.
difficile, pseudomonas, and pandemic flu. 2 Oct 2011
Biogen Idec acquires Dompé joint
ventures
Biogen Idec will acquire 100% of Dompé shares in its
joint ventures in both Italy and Switzerland. 20 Sept 2011
NuGEN and Advanced
Liquid Logic to co-develop digital microfluidic cartridge technology
Advanced Liquid Logic will provide instrumentation, software and
digital microfluidic cartridge technology to NuGEN for
commercialization. 20 Sept 2011
North West Fund
for Biomedical makes first investment in Liverpool start-up
The North West Fund has made its first investment in telemedicine,
in Merseyside start-up company Med ePad. 8 September 2011
Sequenom and
Lifecodexx partner to develop non-invasive test for trisomy 21
The companies have agreed to collaborate in the development and
launch of a trisomy 21 laboratory developed test and other
aneuploidies testing in German speaking countries in Europe. 31
August 2011
Hitachi Aloka
Medical marks European debut at World Congress of Ultrasound in
Medicine and Biology
Hitachi Medical Corporation and Aloka
Corporation have combined their strengths in ultrasound to form
Hitachi Aloka Medical Ltd a subsidiary of Hitachi Medical
Corporation. 24 August 2011
New centre for
radiopharmaceutical development at University Hospital Munich
PET Net GmbH has reached an agreement with the University Hospital
of Munich to install a new center for radiopharmaceutical
development and production. 13 August 2011
apceth granted German licence
to produce somatic cell therapeutics
Munich-based apceth has
become on of the first companies in Germany to be granted a
manufacturer's licence for the production of somatic cell
therapeutics pursuant to Section 13, German Medicines Act. 13 August
2011
Evangelisches
Krankenhaus Bielefeld signs ten-year radiology agreement with
Siemens
German hospital operator Evangelisches Krankenhaus
Bielefeld (EvKB) has signed a ten-year partnership agreement with
Siemens Healthcare to provide and maintain a new radiology suite. 11
August 2011
Mirador Biomedical receives CE
mark for Compass pressure measurement platform
Seattle-based
Mirador Biomedical, Inc has received CE Mark approval and an ISO
13485 Quality Management System Certification for its Compass
platform . 10 August 2011
Aberdeen University spinout to
commercialise antibodies
Vertebrate Antibodies (VAb) Limited
is a new biotech company spun out of the University of Aberdeen to
provide new tools to help researchers trying to understand the
biology and process of diseases that affect humans and animals. 10
August 2011
Opportunities for medical
device manufacturers in motorsport industry
There are many
shared values in the production of components for the medical and
motorsport industries, from the highest degree of engineering
integrity to the paramount value of reliability. 5 August 2011
Granton Medical offers clean
packing solution for surgery-ready products
Sheffield-based
Granton Medical is offering a new service for the healthcare and
medical marketplace, providing a customisable medical device packing
solution. 5 August 2011
Michelson Diagnostics targets
US market for skin cancer imaging products
Michelson
Diagnostics has announced plans to expand availability of its
revolutionary products for skin cancer imaging in the United States
with the formation of a US subsidiary. 5 August 2011
Lophius Biosciences closes €1.4m
additional financing
Lophius Biosciences, a developer of
novel, innovative T-cell-based diagnostic test systems, has
announced the closing of an additional financing round totaling €1.4
million. 5 August 2011
Maxim acquires MEMS developer
SensorDynamics
Maxim Integrated Products has acquired
Austrian company SensorDynamics, a privately held semiconductor
company that develops proprietary sensor and microelectromechanical
(MEMS) solutions. 5 August 2011
Toumaz in joint venture with
CCE to market Sensium Digital Plaster
Toumaz has established
a new joint venture with California Capital Equity to expand the
commercialisation and distribution of the Sensium Digital Plaster.
30 July 2011
Source BioScience receives NHS
approval for automated cervical cancer screening technology
NHS Cancer screening Programmes has approved the use of Source
BioScience BD FocalPoint 'No Further Review' technology for cervical
cancer screening in the UK. 27 July 2011
Pneumacare awarded CE mark for
revolutionary respiratory measurement systems
Pneumacare's
novel PneumaScan devices
that use 3D imaging technology for measuring and assessing
respiration. 27 July 2011
Paris hospitals’ technology transfer arm
generates €17m revenue
Assistance Publique-Hôpitaux de Paris
generated €17 million in revenues thanks
to its technology transfer arm, OTTLIV, in 2010. 27 July 2011
Siemens’ Biograph mMR system receives
FDA clearance
Biograph mMR is the world’s only fully
integrated whole-body molecular MR with simultaneous magnetic
resonance and positron emission tomography data acquisition. 4
July 2011
Xceleron announces new board and
executive appointments
York-based Xceleron has announced that
Dr David Roblin has been appointed to its Board of Directors in a
non-Executive capacity and Dr Stuart Best has joined the company as
Senior Director Operations. 14 June 2011
Plessey Semiconductors wins award
for novel electric field sensor technology
The EPIC sensor is
a completely new area of sensor technology that measures changes in
an electric field in a similar way to a magnetometer detecting
changes in a magnetic field. 9 June 2011
SPARK Impact expands
investment team for North West Fund for Biomedical
Early
stage venture capital company SPARK Impact, which manages the £25m
North West Fund for Biomedical for parent organisation The North
West Fund, has appointed two new staff to its investment team in
Liverpool. 9 June 2011
Sheffield to host event
promoting high-value medtech manufacturing
Organised by
Medilink Yorkshire & Humber, the High Value Manufacturing in
Healthcare event to be held on 29 June, will engage with the UK
healthcare technologies community to look at the issues relating to
high-value added manufacturing. 9 June 2011
Avacta secures second Optim
sale in US
Avacta's marketing partner in the US has secured
the second Optim sale, to one of the ten largest pharmaceutical
companies in the US. 2 June 2011
Capio enhances scientific and
industrial competence with new board members
Swedish company,
Capio, has appointed a new board of directors and management team to
enable further steps in the company’s development. 2 June 2011
French health insurer awards
Healthways contract to manage diabetes nationwide
France’s
Caisse Nationale d'Assurance Maladie des Travailleurs Salariés
(CNAMTS) has awarded US company Healthways in partnership with
French consulting firm Altran a contract to expand services for
CNAMTS’ Sophia program. 20 April 2011
Omron Healthcare wins iF
design awards for blood pressure monitors
Omron Healthcare
Co., has won both the iF Product Design Award and Universal Design
Award for its blood pressure monitors M6 and M6 Comfort. 19 April
2011
Sheffield Precision Medical
expands production
Orthopaedic device manufacturer Sheffield
Precision Medical Ltd (SPML) has expanded production following
record interest in its services. 19 April 2011
IBA takes 25% stake in German
radiopharmaceuticals supplier PET Net
Belgian company Ion
Beam Applications (IBA) S.A. has taken a minority stake in PET Net
GmbH and PET Net Solutions AG, providers of PET radiopharmaceuticals
to nuclear medicine facilities in Germany. 19 April 2011
GE Healthcare and Steris
Corporation extend collaboration
GE Healthcare has renewed
its collaboration with Steris Corporation to continue offering
interventional suites optimized with products from both companies.
Novartis completes merger with
Alcon
Alcon will be a new division in Novartis and the second
biggest in the company after Pharmaceuticals. The division will be
headed by Kevin Buehler, former chief executive of Alcon.
Selvita to provide computational
chemistry services for US Institutes for Pharmaceutical Discovery
Krakow-based Selvita has signed an agreement with US drug discovery
company the Institutes for Pharmaceutical Discovery (IPD) to provide
computational chemistry services. 11 April 2011
British Lung Foundation and
Philips Respironics to raise awareness of obstructive sleep apnoea
UK charity, The British Lung Foundation and Philips
Respironics, have partnered to create a three year programme that
aims to raise public awareness and improve diagnosis of obstructive
sleep apnoea (OSA). 11 April 2011
Avacta Analytical signs
distribution agreement with DKSH Japan
Avacta Group plc has
signed an exclusive agreement for the distribution of Optim, its low
volume protein analysis system, with DKSH Japan. 11 April 2011
Digirad launches Ergo solid
state nuclear medicine camera
Digirad has launched the Ergo,
a new range of solid-state, nuclear medicine cameras. In the UK it
is available from Southern Scientific. 11 April 2011
Olympus Surgical Technologies
Europe takes over Olympus Surgical UK
Hamburg-based Olympus
Surgical Technologies Europe has taken over Olympus Surgical UK, the
fifth company to join the expanding corporate network. 4 April 2011
Esaote International NV and
Pie Medical Imaging acquire 3mensio
Esaote International NV
has taken over 3mensio Medical Imaging BV which has merged with Pie
Medical Imaging BV (PMI), a company of the Esaote group. 4 April
2011
Siemens integrates Maquet OR
table into angiography system
Maquet has announced that
Siemens Healthcare will integrate Maquet’s Magnus operating table in
its Artis zeego and Artis zee ceiling interventional systems. 19
March 2011
University of Marburg tests
nanometer resolution light microscopes for Leica
The
University of Marburg is expanding its cooperation with Leica
Microsystems to test a new generation of light microscopes with a
resolution at the nanometer scale. 19 March 2011
RainDance Technologies and
Ambry Genetics collaborate to develop ADME genetic screening panel
RainDance Technologies, Inc. and Ambry Genetics have announced a new
collaboration for the development of a drug absorption,
distribution, metabolism, and excretion (ADME) genetic screening
panel for use on next-generation sequencing (NGS) systems. 19 March
2011
CEA-Leti and partners to
develop novel injectable tracer for cancer treatment
CEA-Leti
has announced that with four French partners it is developing an
injectable tracer that can provide both nuclear imaging in the
pre-operative evaluation of tumors and optical imaging during
ablation or biopsy. 19 March 2011
Partnership to accelerate
human protein kinase drug discovery
UK company IOTA
Pharmaceuticals, Danish company KinaseDetect and Swedish company
SARomics Biostructures have formed the KINOMED Partnership to
accelerate human protein Kinase drug discovery. 7 March 2011
Astra Tech announces strategic
alliance with 3Shape for lab-based scanning
Astra Tech, a
developer of implant dentistry and CAD/CAM abutments, has announced
a global strategic alliance with 3Shape A/S, the Danish-based
provider of 3D scanners and CAD/CAM software solutions. 4 March 2011
GE Healthcare completes
acquisition of Orbotech Medical Solutions
GE has completed
the acquisition of Orbotech Medical Solutions, a manufacturer of
cadmium zinc telluride (CZT) detectors used in GE Healthcare’s
Alcyone nuclear medicine technology. 22 Feb 2011
Enzybel joins US Science Center Port
Business Incubator
Enzybel International, a Belgian company
dedicated to the production and commercialization of natural
compounds, has established a US office at the University City
Science Center’s Port Business Incubator in Philadelphia. 22 Feb
2011
Agilent Technologies and GE Healthcare
join WIN consortium
The Worldwide Innovative Networking in
Personalized cancer medicine Consortium is a joint initiative from
the Institut Gustave Roussy and the University of Texas MD Anderson
Cancer Center. 22 Feb 2011
Physio-Control and BeneChill partner
to market therapeutic hypothermia system
Physio-Control, a
wholly-owned subsidiary of Medtronic and BeneChill, Inc a pioneer in
portable therapeutic cooling systems have formed a strategic
partnership to launch the RhinoChill IntraNasal Cooling System in
Europe. 22 Feb 2011
Creganna-Tactx Medical and BBA in partnership to provide medical
device consulting services
The partnership will provide Creganna-Tactx
Medical customers with dedicated access to clinical, regulatory
and quality expertise and consulting services. 22 Feb 2011
Microsulis sells microwave
endometrial ablation technology to Hologic
Microsulis Medical
Limited is to discontinue sales of its Microwave Endometrial
Ablation system for gynaecology and female urology and has licensed
the technology to Hologic Inc. 21 Feb 2011
Partek and Ion Torrent in
partnership to distribute genomics software
Bioinformatics
developer Partek Incorporated has signed a distribution agreement
with Ion Torrent Systems, to make the Partek Genomics Suite
available directly through Ion Torrent’s online store. 21 Feb 2011
Sanofi Aventis in US$20bn
takeover of Genzyme
Genzyme will expand Sanofi Aventis'
presence in biotechnology and will become its global center for
excellence in rare diseases.
Care UK expands diagnostic imaging
services to UK GP commissioning consortia
Care UK has
expanded its capability to provide imaging services to GP consortia
through the acquisition of an 80% stake in medical imaging company
SMI Ltd. 15 Feb 2011
STI Capital acquires
Cardionetics
Cardionetics Limited specialises in the
development of advanced algorithms for ECG analysis and this
acquisition gives STI a ready-made range of handheld ECG devices. 7
Feb 2011
DBV Technologies closes
US$25.5m financing round
The company's products are designed
to epicutaneously (via a skin patch) deliver allergens for
epicutaneous immunotherapy (EPIT) against food allergies such as
peanut and milk. 7 Feb 2011
VAXIMM secures a further
CHF7.8m private financing
Swiss biotech firm and Merck KGaA
spin-off VAXIMM AG closed a private financing round totalling CHF7.8
million from new and existing investors in January. 7 Feb 2011
DHL wins US and Brazilian approval for
European contract manufacturing
DHL Supply Chain’s Contract
Manufacturing operation in The Netherlands has passed GMP audits
with the US FDA and the Brazilian FDA ANVISA. 7 Feb 2011
Oxford Medical Diagnostics adds Prof
Graham Richards to Science Advisory Panel
Professor Richards,
head of the Centre for Computational Drug Discovery at Oxford
University, brings his considerable expertise in life sciences and
developing technology-based start-up companies. 7 Feb 2011
Telemis expands in Italy with
acquisition of Micromedica
Belgian medical imaging systems
developer Telemis has further consolidated its position in Italy
with the acquisition of Micromedica Ltd, one of the country’s
leading PACS vendors. 7 Feb 2011
Aureus Pharma changes name to Aureus
Sciences
Aureus Pharma has changed it name and launched a
new web portal to bring better access to its range of advanced drug
discovery tools and knowledge. 7 Feb 2011
Microvisk secures £6 million
to launch world’s first diagnostic SmartStrip
SmartStrip is a
disposable strip that uses embedded sensors to work out the clotting
speed of blood from a finger prick sample and the results are
displayed on a handheld reader. 4 Feb
Microfluidics announces
PureNano as brand name of MRT technology applications
Microfluidics has rebranded its innovative MRT nanoparticle creation
technology as the PureNano platform, featuring the PureNano
Continuous Crystallizer. 4 Feb
Caliper and Seegene partner to
provide multiplex molecular diagnostics products
Caliper Life
Sciences, Inc. and Seegene, Inc. have entered into a strategic
partnership to enable Seegene's SeePlex multiplex diagnostic assays
to run on Caliper's innovative LabChip Dx platform. 31 Jan 2011
Varian receives US clearance
for proton therapy system
Varian Medical Systems has
received FDA 510(k) clearance for its proton Therapy System which
generates protons for precision radiotherapy of lesions, tumours,
and conditions where radiation treatment is indicated. 31 Jan 2011
Caliper and Seegene partner to
provide multiplex molecular diagnostics products
Caliper Life
Sciences, Inc. and Seegene, Inc. have entered into a strategic
partnership to enable Seegene's SeePlex multiplex diagnostic assays
to run on Caliper's innovative LabChip Dx platform. 31 Jan 2011
Real-time vital signs data
provider Isansys Lifecare makes company debut
The new
business will focus on providing continuous, real-time patient data
to healthcare professionals using the Isansys Lifecare Platform. 28
Jan
Kromek wins US$4m contract to
develop advanced breast cancer diagnosis system
The contract
represents one of very few scientific programmes, globally, with the
potential to dramatically improve the way in which breast cancer is
detected and subsequently treated. 21 Jan 2011
Polyplus-transfection raises €2.5 million in latest funding round
This new round brings in new shareholders in Polyplus-transfection,
AIRFI (Alsace Inter Regio Fonds d’Investissement) and Sudinnova,
which have invested €1 million and €0.5 million, respectively. 21
Jan 2011
BD and Bruker collaborate to
transform bacterial and fungal diagnostics
The companies have
formed a co-development and co-marketing collaboration that will
promote an emerging, integrated approach to bacterial and fungal
identification and antimicrobial susceptibility testing. 21
Jan 2011
Siemens Healthcare creates UK
clinical products division for X-ray and ultrasound
The new
division brings together mammography, ultrasound, general X-ray,
fluoroscopy, mobile X-ray and urology imaging under one team to
focus on growing market share. 21 Jan 2011
Hologic acquires uterine
fibroid system developer Interlace Medical
Hologic, Inc. a
developer of diagnostics, medical imaging systems and surgical
products for women's health has acquired Interlace Medical, Inc. a
developer and manufacturer of the MyoSure hysteroscopic tissue
removal system. 13 Jan 2011
Gynesonics receives EU
clearance for uterine fibroid treatment
The VizAblate System
is a transcervical device that combines ultrasound image guidance
with radiofrequency ablation to treat fibroids in an outpatient
setting. 13 Jan 2011
Boston Scientific acquires
deep brain stimulation company Intelect Medical
Boston
Scientific is paying $60m for the company which is developing the
GUIDE DBS programming system, a system to enable clinicians to
visualize stimulation fields in the brain and provide more precise
targeting of therapy. 13 Jan 2011
iCAD completes acquisition of
Xoft
Cancer diagnostic imaging systems developer iCAD, Inc.
has completed the previously announced acquisition of Xoft, Inc.,
developer of the Axxent eBx electronic brachytherapy system. 7 Jan
2011
Thermo Fisher Scientific
completes acquisition of Lomb Scientific
Lomb Scientific is
a provider of laboratory chemicals, consumables and instruments in
Australia and New Zealand. 7 Jan 2011
GE and Russian Technologies
form joint venture to manufacture medical devices
GE and
state corporation Russian Technologies (Rostekhnologii) are to form
a joint venture to manufacture, assemble, sell and service medical
diagnostic equipment in Russia. 7 Jan 2011
Public-private partnerships in
healthcare worldwide worth US$70 trillion up to 2020
The
rapidly increasing costs of healthcare worldwide will spur
governments to use public-private partnerships to improve
efficiencies, according to PwC's Health Research Institute. 6 Jan
2011
Accovion expands presence in
Europe
Accovion has established two additional subsidiaries
in the Czech Republic and in Russia. 21 Dec 2010
Philips partnerships
accelerate development of magnetic particle imaging
Royal
Philips Electronics has initiated a German public-private
partnership to develop whole-body magnetic particle imaging (MPI)
systems and preclinical hybrid systems that combine MPI with
magnetic resonance imaging (MRI). 21 Dec 2010
MDxHealth renews methylation
biomarker agreement with Veridex
MDxHealth SA has renewed its
agreement with Veridex for the use of certain of its proprietary DNA
methylation products in blood testing for colorectal cancer and
prostate cancer screening. 16 Dec 2010
Bio Nano Consulting expands
into China
Bio Nano Consulting (BNC), specialists in bio and
nanotechnology partnerships between the academic and industrial
sectors, has signed up two prominent academics based at China’s
Tsinghua University to its pool of consultants. 16 Dec 2010
Science Warehouse to supply
transaction management systems to Eurofins Scientific
Science
Warehouse will provide its purchasing and transaction management
solutions to the eight Eurofins Scientific sites across the UK. 16
Dec 2010
iSOFT moves into life sciences
market
iSOFT Group Limited has moved into the life sciences
market with software that extracts and de-identifies clinical data
from electronic medical records for clinical research and other
secondary uses. 16 Dec 2010
Plasticell and Sigma-Aldrich
collaborate to develop novel stem cell differentiation protocols
Plasticell will own resulting protocols for high efficiency,
directed differentiation of stem cells, with Sigma-Aldrich marketing
the reporter stem cell lines. 10 Dec 2010
St Jude's five-column
neurostimulation lead gains EU and Australian approval
St
Jude Medical has received European CE and Australian approval for
its Penta surgical lead for neurostimulation therapy. 10 Dec 2010
Covidien receives US clearance
for iDrive powered surgical stapling system
Covidien has
received US FDA clearance for its iDrive powered surgical stapling
system. This reusable stapling platform is battery-powered, enabling
one-handed push-button operation of all primary controls. 10 Dec
2010
Merck gains novel insulin
technology with acquisition of SmartCells
Merck is to
acquire SmartCells, a private company developing a glucose
responsive insulin formulation for the treatment of diabetes
mellitus in a deal worth over US$500m. 10 Dec 2010
Universal flu vaccine to be tested in Indonesia
Australia and Indonesia are collaborating to produce and trial a
universal flu vaccine. The new vaccine, GammaFlu, provides
cross-protection against current influenza viruses as well as any
other unknown strains that may arise in the future. 10 Dec
Genzyme completes sale of
genetic testing business to LabCorp
Genzyme has completed the
sale of Genzyme Genetics to Laboratory Corporation of America
Holdings for $925 million in cash. 10 Dec
Boston Scientific to sell
neurovascular business to Stryker for US$1.5bn
The business
employs approximately 1,150 people and reported 2009 revenues of
US$348 million.
Philips announces new COPD
alliance and medical innovations at Medica 2010
Philips new
alliance is expected to result in better treatment access for
patients. It is also displaying innovations for operating rooms,
healing lighting, patient monitoring and cardiac ultrasound. 17 Nov
2010
GE Healthcare integrates
facility management software with AeroScout's Wi-Fi RFID system
The combined solution adds real-time asset location information to
GE's Maintenance and Facility Management software and helps
streamline key business processes. 17 Nov 2010
Sustainability is key theme
for Siemens at Medica 2010
At this year's
trade fair in Düsseldorf the company will be presenting solutions
that enable hospitals to achieve both their economic and their
environmental goals while at the same time increasing the quality of
patient care. 17 Nov 2010
German medtech sector sales
grow 5.5% in 2010
A survey by BVMed has found that the German
medical technology sector has shown good performance in 2010, with
an increase in sales of 5.5% and are strong in innovation and
growth, creating new jobs. 12 Nov 2010
Bio Nano Consulting completes
transition to self-funding organisation
Bio Nano Consulting
(BNC), specialists in bio and nanotechnology partnerships
between the academic and industrial sectors, has completed its
publicly funded phase of corporate development. 12 Nov 2010
Linde Healthcare launches new
funding for innovative gas-based therapies
German company
Linde Healthcare has launched the Linde Healthcare REALfund to
support and stimulate novel and innovative ideas, research and
projects relating to the use of gases healthcare. 12 Nov 2010
Birmingham University and
Abingdon Health launch diagnostics joint
venture
The University of Birmingham and medical diagnostics
specialists, Abingdon Health Ltd have launched Bioscience Ventures
Limited to develop and market new diagnostics products for the
healthcare and other industries. 12 Nov 2010
Plasticell to collaborate with
UCB to develop small-molecule drugs
UCB will supply
Plasticell with drug compound libraries with known biological
targets. Plasticell will screen these using its CombiCult technology
to discover new cell signalling pathways. 12 Nov 2010
Siemens Healthcare wins UK
Excellence Award
The British Quality Foundation (BQF) has
awarded Siemens Healthcare the UK Excellence Award 2010 in
recognition of outstanding management practice and business
success. 12 Nov 2010
Boston Scientific to sell
neurovascular business to Stryker for US$1.5bn
The business
employs approximately 1,150 people and reported 2009 revenues of
US$348 million.
Venn Life Sciences expands
into France with acquisition of DCI
DCI offers clinical trial
management services for Phase I-IV and contract placement solutions
for clinical research projects. DCI brings extensive knowledge of
the French clinical trial industry. 9 Nov 2010
Dyadem opens office in Germany
Enterprise risk management system supplier Dyadem has opened a
second office in Europe, located in Starnberg, Germany, on the
outskirts of Munich. 9 Nov 2010
Nordson completes acquisition
of Micromedics
Nordson Corporation has completed the
acquisition of St Paul, Minnesota-based Micromedics Inc., a producer
of dispensing biomaterials for controlling bleeding, healing wounds
and other related medical procedures. 3 Nov 2010
IBA to install proton therapy
centre in Tennessee
Belgian company IBA has been awarded a
contract by ProVision Trust and The Proton Therapy Center, LLC
(TPTC) to install a proton therapy facility in Knoxville, Tennessee.
The contract is worth US$70-80 million over 10 years. 3 Nov 2010
GE Healthcare to acquire
Orbotech's nuclear medicine technology
GE Healthcare is to
acquire Orbotech's subsidiary Orbotech Medical Solutions Ltd, a
manufacturer of solid state gamma radiation detectors made of
cadmium zinc telluride (CZT) for medical imaging. 2 Nov 2010
GE Healthcare takes over
molecular diagnostics company Clarient
Clarient is a supplier
of oncology testing and diagnostic services and developer of
companion diagnostic markers for a range of cancers. 2 Nov 2010
Almac integrates drug
development services into new US headquarters
Almac has
completed the first phase of relocating employees from three
business units to the new 240,000 square feet state-of-the-art
integrated drug development facility. 26 Oct 2010
TRaC appoints Chinese partner
for European certification and testing
Regulatory compliance
company TRaC has announced the appointment of Guangzhou Certitek
Testing Service Co Ltd to the TRaC Partner Programme. 26 Oct 2010
Medtronic to distribute
Tissuemed's neurosurgical film
Leeds-based Tissuemed has
entered into a distribution agreement with Medtronic in which
Medtronic will distribute Tissuemed's Obex NeuroFilm Cerebrospinal
Fluid Barrier in markets outside the US. 22 Oct 2010
Leads to Development opens new
offices in London and Lyon
L2D is a pioneering business
created to manage the non-clinical aspects of development projects
for biotech and pharmaceutical companies. 22 Oct 2010
Almac invests $4m in
biocatalysis business
Almac is continuing to both
advance the biocatalysis business and to broaden application of its
biocatalysis expertise with a further US$4m R&D investment. 22 Oct
2010
3M completes acquisition of
Arizant
3M has completed its acquisition of Arizant Inc., a
manufacturer of patient warming solutions designed to prevent
hypothermia in surgical settings. 21 Oct 2010
Nuevolution in collaboration
to develop drugs for epigenetic disorders
Copenhagen-based
Nuevolution is collaborating with EpiTherapeutics, ExpreS2ion
Biotechnologies and the Biotech Research & Innovation Centre (BRIC),
University of Copenhagen, to identify and develop novel small
molecule drugs against epigenetic factors. 21 Oct 2010
Anaxsys secures £1m funding
for respiratory sensor technology
The new investment will
allow Anaxsys to accelerate the commercialization of respiR8, its
first product, and further the development of a range of innovative
respiratory devices. 15 Oct 2010
Untapped resources for UK life
science company start-ups
A new report shows that there are
vast, untapped opportunities to start up and develop life science
companies across the UK. The report calls for public investment to
be better targeted at four UK ‘hot spots’. 15 Oct 2010
Kinaxo and Daiichi Sankyo in
cancer drug development collaboration
German biotechnology
company Kinaxo Biotechnologies GmbH has signed a long-term
partnership agreement with Japanese company Daiichi Sankyo Company
Limited to develop cancer drugs. 1 Oct 2010
Recipharm acquires Abbott's
Spanish biopharmaceutical manufacturing
Swedish company
Recipharm AB has acquired Abbott’s manufacturing site near
Barcelona, Spain for an undisclosed sum.
The site, which will now
be called Recipharm Parets SL. 1 Oct 2010
St Jude gains Japanese
approval for spinal cord stimulation system
St Jude Medical,
Inc. (NYSE:STJ) has received Japanese approval to market its Eon
Mini spinal cord stimulation (SCS) system in the country. 1 Oct 2010
IBA sells first carbon beam
therapy system
Belgian company IBA has sold the prototype of
its next generation carbon therapy system to French company CYCLHAD
and signed an R&D agreement with Saphyn to jointly develop the
potential of carbon beam therapy. 23 Sept 2010
Philips acquires second
Brazilian clinical information systems company
Philips
Healthcare is to acquire a second Brazilian clinical systems
supplier, Wheb Sistemas. It follows the March 2010 acquisition of
Tecso Informatica, one of Brazil’s leading radiology information
systems (RIS) suppiers. 17 Sept 2010
3M acquires Arizant's patient warming
business for $810m
3M has
agreed to acquire Arizant
Inc. for $810 million in cash. Arizant is a manufacturer of patient
warming solutions designed to prevent hypothermia in surgical
settings. 15 Sept 2010
LabCorp in $925m takeover of
Genzyme Genetics
Laboratory Corporation of America Holdings
has agreed to acquire Genzyme Genetics, a business unit of Genzyme
Corp and a leading provider of complex reproductive and oncology
testing services. 15 Sept 2010
Russia assembles first CT
scanner
GE Healthcare and its Russian manufacturing partner
Meditsinskie technologii Ltd (MTL) have unveiled Russia's first
domestically assembled CT scanner. 15 Sept 2010
Canon announces ophthalmic
diagnostics plans following takeover of Optopol
Canon Europe
has announced first details of its plans for world domination in the
ophthalmic diagnostic equipment market. 15 Sept 2010
MorphoSys starts novel drug
development program for MRSA infections
MorphoSys AG has
started a new proprietary development program against novel
infectious disease targets. It is also collaborating with
Sheffield-based Absynth Biologics to access novel target molecules
related to MRSA. 15 Sept 2010
Elemental Healthcare to distribute GI
Dynamics' gastrointestinal liner in UK and Ireland
GI Dynamics has
licensed Elemental Healthcare to distribute its EndoBarrier
Gastrointestinal Liner, a non-surgical therapeutic for the treatment of type 2 diabetes and obesity. 9 Sept 2010
iBio and Fraunhofer partner GE to
develop biotechnology manufacturing systems
iBio, the Fraunhofer
USA Center for Molecular Biotechnology, and GE Healthcare have entered
an agreement to jointly develop and globally market manufacturing
systems for biopharmaceuticals and vaccines based upon their respective
proprietary technologies. 9 Sept 2010
New company combines F1 technology
with physiotherapy for rehabilitation
The Gatherer Partnership, a
new company that combines technology from Formula One racing with the
experience of one of Britain’s most renowned research physiotherapists,
aims to advance patient rehabilitation and conditioning techniques. 9
Sept 2010
Vivacta re-aligns management in
preparation for £4 million financing round
Kent-based
diagnostics technology company Vivacta Limited has announced a change
and re-alignment of its executive management team as it enters an
important phase of partnering and commercialisation. 26 August 2010
Cegedim Dendrite and Capgemini
partner to offer services to life science companies
Capgemini
will provide broad-based consulting and implementation services
associated with Cegedim Dendrite’s AggregateSpend360 and Nucleus 360
solutions to pharmaceutical, biotech and medical device companies. 18
August 2010
Scancell licences human antibody
from Cancer Research Technology
Cancer Research Technology has
licensed Nottingham University spinout Scancell Holdings to use a human
antibody known as 105AD7. 18 August 2010
Cytori’s PureGraft receives EU
approval for fat grafting procedures
Cytori Therapeutics has
received the CE Mark for the PureGraft 250/PURE System for autologous
fat grafting procedures. It is aimed at the cosmetic and reconstructive
surgery market. 18 August 2010
Akonni Biosystems’ ultra-rapid
nucleic acid extraction technology gains US patent
The patent
protects the company’s use of its pioneering nucleic acid binding matrix
when inserted into a pipette tip, tubing or cartridge for nucleic acid
purification. 18 August 2010
Medical equipment deals briefing for Q2 2010
Mergers and acquisitions
activity decreased. There was a decrease in value over Q1 mainly due to
a large acquisition by Novartis in Q1. The number of deals also
decreased from 110 in Q1 to 78 deals in Q2 2010. The most active buyers
were Essilor
International with 14 deals, followed by Covidien plc with eight.
more ...
Epson partners with Philips to
offer printing systems for ultrasound imaging worldwide
Epson
America and Royal Philips Electronics have entered into an agreement
to supply Epson ink jet printers with Philips ultrasound medical
imaging systems around the world. 17 August 2010
Ion Torrent licences DNA
Electronics technology
DNA Electronics Ltd has signed a
worldwide licence agreement giving Ion Torrent access to its
intellectual property. DNA Electronics has developed scalable
semiconductor solutions for real-time nucleic acid detection. 13
August 2010
iSOFT partners i-Path to add
digital pathology to laboratory system
iSOFT is adding
i-Path’s web-based platform as a module to its existing laboratory
product suite. The aim is to deliver the solution under a
software-as-a-service model. 13 August 2010
TRaC accredited for
IEC/EN60601 medical device testing
TRaC is now able to offer
a cost-effective route to product certification. Approval under the
standard is a fundamental requirement before a manufacturer can
market any electrical device for patient diagnostics, monitoring or
care. 13 August 2010
Clontech Laboratories and TET
Systems extend gene expression systems license agreement
Under the expanded license agreement, Clontech obtains rights to
develop, manufacture and commercialize novel Tet Systems products
such as the Tet-On 3G Inducible Expression System. 11 August 2010
Pharmaceutical Development
Services and Schiff & Company form alliance
PDS will be
providing Regulatory and Quality Services to Schiff & Company
clients in Europe while Schiff & Company will be targeting US based
companies looking for local assistance in Europe. 11 August 2010
Siemens wins 15-year €132m
medical imaging contract in Spain
Siemens will provide the
Cartagena and Mar Menor hospitals with more than 100 imaging
systems, including computed tomography scanners, mammography
systems, and ultrasound systems. 11 August 2010
Philips acquires Israeli PACS
supplier CDP Medical
Philips has agreed to acquire the
business of CDP Medical Ltd, an Israel-based provider of picture
archiving and communication systems (PACS), and a subsidiary of
medical device distributor Medtechnica Ltd. 2 August 2010.
Philips acquires Chinese
ultrasound transducer producer Shanghai Apex Electronics Technology
The acquisition strengthens Philips’ portfolio of high quality
transducers specifically aimed at the value segment in emerging
markets. 2 August 2010
Varian and Brainlab Combine
TrueBeam STx with the Novalis Radiosurgery Program
Varian
Medical Systems and Brainlab are expanding their radiosurgery
partnership to incorporate their Novalis technology and other
Novalis radiosurgery program elements into the recently launched
TrueBeam STx system. 2 August 2010
Cambridge Crystallographic Data Centre
and InhibOx partner to offer drug development services
The
combined service offers pharmaceutical, biotech and governmental
research organizations access to new capabilities to accelerate drug
discovery and improve productivity. 2 Aug 2010
Target Health joins forces
with LifeOnKey to offer clinical trials platform
Target
Health and LifeOnKey are partnering to offering a platform for the
bio-pharmaceutical and medical device industries to optimize
clinical trials help researchers capture, analyze and assess trial
data more efficiently. 26 July 2010
Medical Device Consultants in
partnership with Clinical Development & Support Services
US
contract research organization (CRO) Medical Device Consultants,
Inc. (MDCI) has announced a strategic partnership with Clinical
Development & Support Services Ltd (CDSS), a clinical services and
CRO based in Cheshire, UK. 26 July 2010
Health Robotics expands
CytoCare market into Spain and Portugal
Health Robotics has
announced it has granted exclusive rights to Grifols S.A. to
distribute its CytoCare chemotherapy system in Spain and Portugal.
26 July 2010
BRAIN takes share in
Enzymicals
German biotechnology company BRAIN AG has acquired
a minority share in chemical and biocatalyst specialist Enzymicals
AG. The move enhances the activities of both companies in the
biocatalysis sector. 15 July 2010
Covidien completes acquisition
of ev3
Covidien has announced the completion of the
acquisition of ev3 Inc. for approximately US$2.6 billion. The
transaction accelerates Covidien’s strategy of building a
world-class vascular platform addressing high-growth markets. 15
July 2010
P2i expands nano-coating
portfolio with acquisition of Surface Innovations
Abingdon
based P2i Limited, a world leader in liquid repellent nano-coating
technology, has acquired Surface Innovations Ltd, a UK-based
technology company with a wide range of functional nano-coating
patents. 15 July 2010
St Jude Medical completes
takeover of LightLab Imaging
St Jude Medical has completed
the acquisition of LightLab Imaging, Inc. for approximately $90
million in cash. LightLab is a pioneer and leader in the development
of Optical Coherence Tomography (OCT), a high resolution diagnostic
coronary imaging technology. 14 July 2010
Alcon to acquire cataract
surgery laser developer LenSx Lasers
Alcon, Inc. has agreed
to acquire LenSx Lasers, Inc, a privately held company that
developed the first femtosecond laser to receive US FDA clearance
for use as a part of cataract surgery. 14 July 2010
Roche Applied Science
Industrial Business relaunched as Roche Custom Biotech
The
relaunch is to increase brand recognition in the life science,
pharmaceutical, and diagnostic industry. 14 July 2010
Proton therapy company formed
to establish network of treatment centres
Proton Therapy USA
and CareCapital plc have formed a new company, Proton Therapy Global
Management, to design, develop and manage a global network of proton
therapy centres. 30 June 2010
Pharmimage adds members and
extends research platform
Pharmimage, a French group
specialized in the use of imaging to measure the efficacy of new
therapies for the pharmaceutical industry, has acquired four new
members and plans two major additions to its research resources. 23
June 2010
Centocor Ortho Biotech
acquires lung disease portfolio in takeover of Respivert
Centocor Ortho Biotech Inc., a subsidiary of Johnson & Johnson, has
acquired RespiVert Ltd., a privately held drug discovery company
focused on developing small-molecule, inhaled therapies for the
treatment of pulmonary diseases. 23 June 2010
Polyplus-transfection licenses
mammalian transient transfection technology to Kempbio 14 June
2010
Biotage extends peptide
research collaboration with University of Copenhagen
Biotage
has extended a research collaboration with the University of
Copenhagen to develop new applications on the Biotage Syro Wave in
the field of synthetic peptide and protein chemistry. 12 June 2010
Almac and University College
Cork collaborate in solid state chemistry
UCC and Almac have
launched an academic/ industrial collaboration in the field of solid
state chemistry to advance drug development. 12 June 2010
Giltech and B1 Medical
collaborate to develop biodegradable suture anchor
Scottish
companies Giltech and B1 Medical have signed an agreement to jointly
develop a pioneering suture anchor that biodegrades in a controlled
fashion. 8 June 2010
Cellnovo and Home Diagnostics
form alliance to advance diabetes monitoring
London-based
Cellnovo and US company Home Diagnostics, Inc. have formed a
strategic alliance to integrate their diabetes care technologies and
develop distribution opportunities for Cellnovo’s insulin patch
pumps. 8 June 2010
Intercell acquires monoclonal
antibody technology from Cytos Biotechnology
Cytos'
technology is based on expression cloning of monoclonal antibodies
from human B-cells and enables the identification of anti-infective
antibodies to prevent and treat infectious diseases. 8 June 2010
Elekta acquires
ultrasound-guided radiation therapy technology from Resonant Medical
Inc
Elekta has acquired Canadian company Resonant Medical
Inc. (RMI), specialists in image-guided radiation therapy for cancer
treatment. 2 June 2010
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics
The report provides comprehensive understanding and unprecedented
access to the merger and acquisition (M&A) agreements entered into
by the worlds leading biopharma companies. Fully revised and updated, the report provides details of merger and
acquisition agreements from 2003 to end 2009.
More information and Buy online May 2010
Particle Sciences offers
microfluidics reaction technology for nanoparticle production
Particle Sciences and Microfluidics have extended their
collaboration with the placement of the newly-announced
Microfluidics Reaction Technology (MRT) system for pharmaceutical
production at Particle Sciences. 10 May 2010
Global economic downturn will
shrink life sciences sector and R&D spend
Curbing costs in
response to the global economic downturn, as well as the continuing
capital crunch, is likely to have a long-term impact on the life
sciences industries, according to a new white paper released by
Deloitte Touche Tohmatsu. 10 May 2010
Olympus merges minimally
invasive diagnostics expertise into Olympus Surgical Technologies
Europe
Olympus Winter & Ibe GmbH, Celon AG and Olympus
Medical Products Czech SPOL SRO have joined forces to create a new,
single brand. 14 April 2010
Phico Therapeutics raises
further £1.8m to develop new class of superbug antibiotics
Cambridge based Phico Therapeutics, has raised £1.8 million from
their recent funding round of institutional investors and business
angels to develop new treatments for drug-resistant 'superbugs'. 2
April 2010
Evotec in deal with Hypha
Discovery to enhance drug discovery platform
The deal gives
Evotec's screening clients access to Hypha’s MycoDiverse natural
product collection for use as part of its hit-and-lead services to
identify medicinal compounds. 2 April 2010
Eden Biodesign and Millipore
in partnership to offer pharmaceutical manufacturing and gene
expression technology
The partnership that will provide
biopharmaceutical companies with access to a combination of Eden’s
cGMP manufacturing and Millipore’s Ubiquitous Chromatin Opening
Elements expression technology. 1 April 2010
Future-proofing healthcare
innovation in Yorkshire
Healthcare industrialists, clinicians
and academics identified future challenges and opportunities for the
industry and highlighted the need for high-level innovation at a
workshop in Leeds earlier this month run by the newly formed
Yorkshire Health Innovation Network. 26 March 2010
Evotec signs agreement with
Active Biotech for high throughput molecular screening
Evotec AG has entered into a collaboration with Active Biotech
AB to identify small molecule modulators of a priority biological
target, selected by Active Biotech, involved in immune disorders and
cancer. 26 March 2010
Leica Microsystems acquires
Genetix to strengthen life science imaging portfolio
Leica
Microsystems has acquired UK company Genetix Ltd, a provider of
systems for imaging and image analysis for clinical research. 25
March 2010
FASILIS project invites
innovative medical technology businesses to participate
The
European FASILIS project is inviting SMEs or start-ups develloping
telecare technology to apply for financial vouchers that will give
them access to top quality international research and development
facilities and their services across Europe. 25 March 2010
Cresset establishes new
division to provide computation chemistry tools
Cresset has
launched Versaphor, a new desktop applications division aimed at
supplying high quality computational tools based on its molecular
fields technology to a range of markets, including: medicinal
chemists. 25 March 2010
MedilinkWM extends business
service to assisted-living market
The service, myM-Link,
delivers access to business opportunities and information services
to its members, and a host of tangible benefits that are tailored
and dedicated to businesses operating in the UKs assisted living
market. 16 March 2010
Avo Photonics systems
available in Europe
Avo Photonics and German company AMS
Technologies have entered into a distribution agreement that
entitles AMS Technologies to represent Avo’s capabilities to the
European market. 12 March 2010
WuXi PharmaTech's Shanghai
analytical testing facilities gain GMP certification
The
company has received European GMP compliance certification for its
c-GMP drug product manufacturing and analytical testing facilities.
9 Mar 2010
MedilinkUK and MEDEC partner
with UTEK to increase licensing and partnering opportunities
Through this partnership, hundreds of new companies can take
advantage of UTEK's growing network of registered companies and
industry professionals, all looking to identify licensing and
partnering opportunities worldwide. 9 Mar 2010
Evotec extends research
agreement with Cubist Pharmaceuticals
Under the contract
extension, Evotec will provide additional fragment-based drug
discovery expertise using its proprietary platform, EVOlution. 5 Mar
2010
Lilly, Merck, and Pfizer
co-operate to accelerate cancer research in Asia
The three
companies have formed the Asian Cancer Research Group, to accelerate
research and ultimately improve treatment for patients affected with
the most commonly-diagnosed cancers in Asia. 23 Feb 2010
PositiveID acquires
non-invasive glucose detection technology with takeover of Easy
Check
PositiveID Corporation has acquired intellectual
property rights and assets of Easy Check Medical Diagnostics, LLC,
to expand its portfolio of non-invasive glucose-level testing
products and diabetes management tools under development. 23 Feb
2010
Celtic Pharma Holdings and
PolyTherics announce investment to develop novel biopharmaceuticals
The research programme will be undertaken jointly by PolyTherics and
Cantab BioPharmaceuticals Limited, a subsidiary of CP2 based in
Cambridge, UK, and the investment will be by Leverton Licence
Holdings Limited (LLH), another subsidiary of CP2. 22 Feb 2010
Quanticate
appoints head of new
pharmacovigilance
services team
The new
pharmacovigilance service offers clinical trial and post-marketing
pharmacovigilance in order to provide comprehensive surveillance
throughout the product lifecycle. 16 Feb 2010
Isogenica in partnership with
Phylogica
Isogenica Ltd has entered into an agreement with
Australian-based biopharmaceutical company Phylogica to use Isogenica’s
CIS display technology to optimize the performance of three of
Phylogica’s lead compounds targeting CD40 ligand (CD40L). 15 February
2010
Domainex and Pharmidex form drug
discovery services alliance
Domainex Ltd and Pharmidex have formed a strategic alliance, combining
their expertise and innovative technologies to provide the market with
an integrated, high-quality drug discovery services platform. 11 Feb
2010
Fujitsu joins TRaC partner
laboratory programme to support CE certification
Fujitsu General EMC Laboratory Limited has joined the TRaC Partner
Laboratory Programme that offers enhanced services to manufacturers
wishing to certify products for sale in the UK and Europe. 11 Feb 2010
Awards for West Midlands medtech
companies
International demand for infection control solutions and cost-effective
manufacturing tools has helped five groundbreaking businesses from the
UK West Midlands win awards in the Medical and Healthcare Business
Awards 2010, organised by MedilinkWM. 9 Feb 2010
Report on Swedish life science
cluster
Stockholm-Uppsala Life Science has published a comprehensive report on
the research expertise in the Stockholm-Uppsala region of Sweden.
The region currently hosts over 500 life science companies, 300 major
research projects and more than 25,000 employees. 9 February 2010
St Jude Medical gains EU approval
for high power ICD and CRT-D devices
St Jude Medical,has announced European CE Mark approval and first
implants of its Fortify and Fortify ST implantable cardioverter
defibrillators and Unify cardiac resynchronization therapy
defibrillator. 9 Feb 2010
QIAGEN Unit and Pfizer in
agreement to develop diagnostic kit for brain tumours
The companies will develop a companion diagnostic test kit for
PF-04948568 (CDX-110), an immunotherapy vaccine in development for the
treatment of glioblastoma multiforme (GBM). 9 Feb 2010
ISCO opens new facility for stem
cell products
International Stem Cell Corporation has opened its new production
facility in California that will enable development and manufacturing of
clinical-grade products using its human parthenogenic stem cell
technology. 9 Feb 2010
Sorin releases new Paradym CRT
defibrillator
Sorin Group has announced FDA approval and first implant of its
next-generation of cardiac resynchronization therapy defibrillator
(CRT-D), Paradym CRT Model 8750. 9 Feb 2010
Automation Partnership and
Loughborough University in five-year collaboration to develop
regenerative medicine. 5 Feb 2010
Report: Medical Equipment Monthly Deals Analysis — January 2010
The report provides detailed information on M&A, Equity/Debt Offerings,
Private Equity, Venture Financing and Partnership transactions
registered in the medical equipment industry in December 2009. Jan 2010
Buy this report online ...
Syntaxin announces appointments of
senior officers
Syntaxin, a biotechnology company developing novel biopharmaceuticals
that control cell secretion, has announced the appointment of a Chief
Executive Officer, Chief Business Officer and Chief Development Officer.
1 Feb 2010
Peakdale Molecular in chemistry
research collaboration with Pfizer Laboratories
UK research services company Peakdale Molecular Limited has entered into
an agreement with Pfizer Limited to supply custom synthetic chemistry
services. 1 Feb 2010
NASA to develop microfluidics
technology for space-based research with Raydiance
Raydiance Corporation, developer of an ultrafast laser, is partnering
with NASA Ames Research Center to develop advanced microfluidics devices
for space-based biological experiments. 28 Jan 2010
Medtronic to expand cardiovascular
products with acquisition of Invatec
Medtronic, Inc. will acquire Invatec, and two affiliated companies:
Fogazzi and German company Krauth Cardiovascular. The takeover will cost
Medtronic up to US$500m. 28 January 2010
GE Healthcare invests in global
health R&D centre in Korea
GE Healthcare, Incheon Free Economic Zone (IFEZ), and gene analysis
technology company BRC, have announced a five-year plan to invest in the
establishment of the GE Global Ubiquitous Health Research and
Development Center. 14 Jan 2010
Nexstim’s navigated brain
stimulation for neurosurgery planning receives FDA approval
Nexstim Oy, a medical device company has received US FDA appproval for
its navigated brain stimulation system for use in the assessment of the
primary motor cortex for pre-procedural planning. 17 December 2009
ATS Medical gains CE approval for
ATS 3f Enable aortic valve
platform that combines the novel 3f tubular pericardial valve design
with its superior hemodynamic profiles and a self-expanding frame to
hold the valve in its optimal position. 17 Dec 2009
European 'incubator' to accelerate
medical device development launched
The European Medical Device Accelerator (MDA) based at the Science Park
next to Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland,
aims to accelerate the development of revolutionary medical device
technology ideas in Europe. 15 December 2009
Lifebridge gains FDA clearance for
cardio-pulmonary support device
German-based Lifebridge AG has received clearance from the US FDA for a
compact, lightweight, mobile heart-lung machine, a first for any
manufacturer worldwide. 15 Dec 2009
Open source initiative offers
cheaper, rapid development path for medical devices
A unique medical innovation initiative launched by Cranfield University
could shape the way the medical device sector introduces new
innovations. 4 December 2009
Toumaz Technology named emerging
technology company of the year
Toumaz Technology Limited, producer of ultra-low power wireless
infrastructure for body monitoring solutions has been named “Emerging
Technology Company of the Year” by the National Microelectronics
Institute (NMI), the premier trade association representing the
semiconductor industry in the UK and Ireland.
Nolato Medical expands Swedish
Technology Centre
Nolato Medical is expanding its Technology Centre in southern Sweden to
meet increased demand from its customers for more complex medical device
product development. 25 Nov 2009
Olympus opens technology centre for
high energy medical products in Czech Republic
Olympus subsidiary Olympus Winter & Ibe has opened a new
technology centre in the Czech city of Přerov to manufacture products
such as high-frequency generators, applicators for bipolar
high-frequency ablation, electrodes for urology, and electrical
instruments used in surgery.
PPD to Acquire Excel PharmaStudies
Global contract research organization PPD, Inc. is to acquire Chinese
company Excel PharmaStudies, Inc. a market leader and one of the largest
contract research organizations in China. 12 November 2009
Manhattan Scientifics and Senior
Scientifics collaborate to develop cancer cell detection system
Manhattan Scientifics and Senior Scientific, LLC are co-operating to
commercialize Senior Scientific’s magnetic needle leukemia cancer cell
detection invention based on the use of nanoparticles. 12 November 2009
Agilent and Stanford University to
build breakthrough sub 10 nanometre scale devices
Agilent Technologies Inc. (NYSE: A) is collaborating with Stanford
University to study using scanning probe microscope and atomic layer
deposition to build devices with breakthroughs in sub 10 nm scale 12.
November 2009
Boston Scientific launches Promus
Element Stent System in Europe
Boston Scientific has announced EU approval and the launch in Europe of
its Promus Element Everolimus-eluting coronary stent system. 3 Nov 2009
Abbott completes acquisition of
Evalve
Abbott (NYSE:ABT) has announced that it has completed its acquisition of
Evalve, Inc., a developer of devices for minimally invasive repair of
mitral valves. 3 Nov 2009
Eurogentec to acquire proteomics
developer AnaSpec
Belgian biotechnology lab products supplier Eurogentec S.A. has
announced it has entered a final agreement for the acquisition of
california protemics developer AnaSpec, Inc. 30 October 2009
Microbix and Hunan
Biopharmaceutical to build Asia's largest flu vaccine facility
Canadian vaccine technology company Microbix, has signed a joint venture
agreement with the Hunan Biopharmaceutical Co. Ltd. for initial
financing to construct a vaccine production facility with capacity for
100m doses of seasonal flu and 300m doses of pandemic flu. 27 Oct 2009
Sinovac obtains third H1N1 vaccine
order from Chinese Government
Sinovac Biotech Ltd. (NYSE:SVA), a leading provider of biopharmaceutical
products in China, has received its third purchase order for its H1N1
vaccine, PANFLU.1, from China's Ministry of Industry and Information
Technology for the national stockpiling plan. 29 Oct 2009
eBioscience acquires Bender
MedSystems' immunoassay technology
eBioscience Corporation has acquired privately held Austrian immunoassay
technology pioneer Bender MedSystems GmbH in an all cash transaction. 29
Oct 2009
GE Launches $250m Healthymagination
Fund for healthcare technology ventures
GE's new equity fund will make investments in highly promising
healthcare technology companies globally that have innovative
diagnostic, IT, and life sciences technologies. 27 October 2009
Siemens integrates Trumpf’s OR
table in its Artis angiography systems
Siemens Healthcare has integrated the TruSystem7500 operating table from
Trumpf with its C-arm systems Artis zee ceiling and Artis zeego. 27
October 2009
Devlin Electronics to launch
Medical division at Medica
Devlin Medical will be launched at the Medica Exhibition in Dusseldorf
in November (18-21). Devlin Medical is dedicated to the development of
innovative point-of-care computing systems. 27 October 2009.
3M Drug Delivery Systems expands
with new Singapore lab
The Singapore lab will develop products in both the inhalation and
transdermal drug-delivery categories for pharmaceutical customers and
patients in the Asia Pacific region. 23 October 2009
Kinaxo and Bayer Vital collaborate in
cancer biomarker identification
Kinaxo will apply its quantitative phosphoproteomics technology
PhosphoScout for the identification of novel biomarkers in a clinical
trial conducted by Bayer Vital. 21 Oct 2009
Siemens wins $135 million service contract
from US health system
The University of Pennsylvania Health System has awarded Siemens
Healthcare a $135 million
contract for integrated service management for diagnostic systems and bio-medical
devices. 21 Oct 2009 Deutsch
Medifacts wins $2.7m contract for
cardiac monitoring in clinical trial
Medifacts International Inc, has been awarded the contract to provide
comprehensive cardiac safety and efficacy services for a large
late-stage clinical trial. 20 Oct 2009
Medical Equipment Industry Deals Analysis — September 2009
An essential source of data and trend analysis on the mergers and
acquisitions and financings in the medical equipment market. The report
provides detailed information on M&A, Equity/Debt Offerings, Private
Equity, Venture Financing and Partnership transactions registered in the
medical equipment industry in August 2009. The report portrays detailed
comparative data on the number of deals and their value in the last six
months subdivided by deal types, segments, and geographies.
Additionally, the report provides information on top financial advisory
firms in the medical equipment industry. Oct 2009
more ...
SynCardia’s companion driver system
for artificial heart receives CE Mark
SynCardia Systems, Companion Driver System has received CE Mark approval
to power the Total Artificial Heart in Europe. 20 Oct 2009
Cochlear and NXP Semiconductors
collaborate to produce IC devices for advanced hearing implants
The agreement includes the definition, development and supply of
ultra low power speech processor and wireless communication ICs to be
used in Cochlear’s next generation products. 20 Oct 2009
Serametrix Partners with the Ludwig Institute for Cancer Research
to develop and commercialize serum-based diagnostics
This new alliance will enable rapid development and commercialization of
tests that predict and monitor drug response in cancer patients. 20 Oct
2009
Baxter receives EC approval for
Celvapan H1N1 pandemic flu vaccine
Celvapan H1N1 is the first cell culture-based and non-adjuvanted
pandemic influenza vaccine to receive marketing authorization in the
European Union. 14 Oct 2009
Claros Diagnostics receives ISO
13485 certification for point-of-care blood-test system
Claros Diagnostics, a developer of novel point-of-care immunoassay
systems, has reported the receipt of corporate ISO 13485 and CMDCAS
certificates of registration issued by the National Standards Authority
of Ireland (NSAI). 14 Oct 2009
Corning increases lab portfolio
with acquisition of Axygen BioScience
Corning Incorporated has acquired all the shares of Axygen BioScience,
Inc. and its subsidiaries from American Capital Ltd. (Nasdaq:ACAS) for
approximately US$400 million in cash. 9 October 2009
French biotech companies seek UK
partners: BIOMED-Connect Oct 12, London
The London Branch of Maison de la Région Languedoc-Roussillon, with
support from the London Technology Network, is holding BIOMED-Connect, a
business convention, on Monday October 11th from 2.00pm to 9.00pm open
to all companies in the medical technology sector. 7 October 2009
Acrobot and Finsbury Orthopaedics
sign co-marketing agreement
Acrobot, a developer of computer-assisted orthopaedic surgery products
has announced a co-marketing arrangement with orthopaedic implants
company, Finsbury. 5 October 2009
AorTech licenses heart valve to
SynCardia for use in artificial heart
This agreement licenses the use of AorTech’s Elast-Eon polymer heart
valve (PHV) in the SynCardia Total Artificial Heart, as well as the
company’s future family of pulsatile products. 23 Sept 2009
Cardinal Health spin-off CareFusion
starts trading on NYSE
CareFusion Corp. was launched as an independent, publicly traded company
at the beginning of the month. CareFusion products include Pyxis
automated dispensing systems, Alaris IV pumps, ChloraPrep V. Mueller
surgical instruments. 21 Sept 2009
eBioscience corporation acquires
NatuTec GmbH
eBioscience Corporation, a San Diego-based producer of cell analysis
reagents to biotechnology laboratories has announced the acquisition of
Frankfurt-based NatuTec GmbH, a distributor of high-quality biological
research reagents. 21 Sept 2009.
Abbott to acquire cardiac valve
device company Evalve
The acquisition provides Abbott with a presence in the growing area of
non-surgical treatment for structural heart disease for a cost of up to
$410 million. 21 Sept 2009
IDRI licenses NanoPass microneedle
technology for intradermal delivery
IDRI has licensed NanoPass' proprietary MicronJet microneedle technology
for the intradermal delivery of products against a number of diseases
including tuberculosis, HIV, malaria, leishmaniasis and leprosy. 10 Sept
2009
NeuroLogica announces FDA clearance
for inSPira HD: portable high resolution SPECT
The inSPira HD is a battery-powered, high resolution, portable SPECT
designed primarily for brain imaging. 5 Sept 2009
GE Healthcare and TomTec Imaging
Systems co-operate in cardiology IT
GE Healthcare and TomTec Imaging Systems GmbH, have entered into a
formal strategic co-operation contract to improve their echocardiography
systems. 5 September 2009
Sectra signs multi-year contract
with Nordic region’s largest radiology company
Sectra and Norwegian company Curato have signed a six-year partnership
agreement for Sectra’s RIS/PACS products and services in a contract
worth about SEK 100 million.
Lab21 to provide AdnaGen’s tumour
cell detection system UK and Ireland
Lab21 Ltd and AdnaGen AG have entered into an exclusive service and
distribution agreement for AdnaGen’s proprietary circulating tumour cell
diagnostic assays in the United Kingdom and Ireland. 26 August 2009
Norway prepares for swine flu with
purchase of 150 Maquet ventilators
Maquet Nordic and Puls AS have announced that they have won a SEK15
million order from the Norwegian Health Authority (Helsedirektoratet)
for 140 of its Servo-i ventilators to supply hospitals across Norway
during August 2009. 26 August 2009
Siemens and Impac expand co-operation
in oncology information systems
The partnership will give Siemens customers access to Impac’s oncology
information system (OIS) will develop interfaces for their software to
interoperate. 20 August 2009
Deutsch
SonoSite completes acquisition of
CardioDynamics
CardioDynamics will become a wholly-owned subsidiary of SonoSite, Inc.
The transaction is valued at approximately $10.0 million. 20 August 2009
Universal flu vaccines to be
developed under Inovio and US Vaccine Research Center collaboration
The VRC and Inovio will pool technologies to develop the vaccines as
well as rapidly advance development of vaccine candidates targeting the
emerging pandemic 2009 H1N1 swine flu strains. 20 August 2009
Omnio Healer selects Eden Biodesign
for production of wound healing and anti-infection products
Eden Biodesign will provide process development and production services
for Omnio Healer’s wound healing and anti-infection products for
supplying the products for clinical trials. 20 August 2009
Ichor awarded US$3.3m grant to
develop DNA-based Alzheimer’s disease vaccine
Ichor Medical Systems of San Diego has been awarded the grant from the
US National Institute of Neurological Disorders and Stroke (NINDS) for
development of the vaccine and studies required to support eventual
initiation of human clinical testing. 20 August 2009
ImmunoVaccine Technologies partners
with Scancell to advance DNA vaccine delivery
Canadian company IVT has signed an agreement with UK-based Scancell Ltd
to explore the potential of using IVT's DepoVax delivery system for
Scancell's novel ImmunoBody DNA vaccines. 17 August 2009
Turkish Hospital Group orders four
RapidArc radiotherapy systems
Acibadem Healthcare Group has acquired four additional radiotherapy
treatment machines from Varian Medical Systems and expanded its
radiotherapy facilities with new centres in Adana and Kayseri. 17 August
2009
Sigma-Aldrich offers customisable
synthetic extracellular matrix for stem cell research
Under an agreement with Glycosan BioSystems, Sigma-Aldrich can offer the
HyStem platform for stem cell research. This consists of hydrogel cell
culture scaffolds that provide a complex, three-dimensional environment
in which cells are able to proliferate. 17 August 2009
LabCorp completes acquisition of
Monogram Biosciences. 9 August 2009.
Promega expands life science
products with takeover of Turner BioSystems. 9 August 2009
Leica Microsystems and A Menarini
Diagnostics extend distribution agreement
Leica Microsystems GmbH and A Menarini Diagnostics Srl have signed a
five-year agreement to extend their successful co-operation in
distributing Leica products in Europe. 7 August 2009
Covidien to acquire Power Medical
Interventions
Covidien has announced that the company has reached a definitive
agreement to acquire Power Medical Interventions, Inc. a provider of
computer-assisted, power-actuated surgical cutting and stapling
products, for approximately $64 million. 31 July 2009
Agilent Technologies to acquire
Varian for $1.5 billion
Varian, Inc has agreed to a takeover by Agilent Technologies Inc.
Agilent will pay $52 cash per share of common stock for Varian in a
transaction that represents a premium of approximately 35% to Varian’s
closing price on July 24, 2009. 29 July 2009
Industry experts in partnership to
stimulate UK medical technology sector
The team behind the UK Access to Finance for Healthcare Technology
Companies programme has today announced an alliance with two of the
leading organisations in the regional medical technology sector. 2 July
2009
Rubicon Genomics introduces
PicoPlex single cell whole genome amplification kit. 2 July 2009
BioSante Pharmaceuticals and Cell
Genesys sign merger agreement. 2 July 2009
GE Healthcare and Geron in global
agreement to commercialize stem cell drug discovery technologies. 2
July 2009
GlaxoSmithKline signs contract for
Phase Forward clinical trials software. 2 July 2009
Nucletron strengthens position in
cancer radiation therapy market
Dutch radiation therapy systems company Nucletron BV has announced the
creation of an exclusive partnership and plan to merge with sector peer
Isodose Control BV. 29 June 2009
Vivacta raises US$4.5 million to
commercialise piezofilm technology for point-of-care diagnostic tests
Kent-based diagnostic technology company Vivacta has announced that
following successful development of its thyroid function test, it has
closed a financing round that was fully subscribed by existing
investors. 18 June 2009
Aircraft Medical acquires
anaesthesia monitoring technology from Morpheus Medical
Morpheus' lead product, the IoC-View, is designed to measure the level
of consciousness during general anaesthesia, helping to avoid the risk
of patients remaining conscious during surgery. 17 June
European medical technology sector
weathering storm but expecting tougher times
A recent survey by Eucomed of medical technology manufacturers across
Europe has found that the recession was having a significant negative
impact on only 20% of the companies. 8 June 2009
Deutsch
Francais Español
Medtronic and Lilly partner to
improve delivery of diabetes education
Medtronic and Eli Lilly have entered a strategic marketing collaboration
to support each other's commitment to help people with diabetes manage
their blood sugar using insulin therapy. 5 June 2009
Oxford Biosensors placed in
administration following funding withdrawal
Biotech Company, Oxford Biosensors has been put up for sale following
the appointment of administrators. The company has developed unique
technology for point-of-care electrochemical testing for lipids and
other analytes, for use in the cholesterol, diabetes and renal function
diagnostic testing markets. 4 June 2009
Nanogen enters asset purchase
agreement with Elitech and files for bankruptcy
Nanogen, Inc., developer of molecular and rapid diagnostic products, has
executed an asset-purchase agreement with French company Elitech Group,
a privately held diagnostics company, to acquire substantially all of
the assets of Nanogen. 28 May 2009
RaySearch enters partnership with
Siemens
Swedish company RaySearch Laboratories AB has entered into a long-term
development and licensing agreement with Siemens Healthcare in which
RaySearch will provide a number of treatment planning modules that will
be integrated in Siemens’ syngo Suite for Oncology. 28 May 2009
Thin-film battery revenues to come
from medical devices, sensors and watches
Thin-film batteries are being designed as energy storage devices for
small photovoltaic or thermoelectric systems to create ultra-long-lived
power sources for medical devices, sensors and watches. 19 May 2009
Biotech business model
unsustainable in current economic crisis
The global biotechnology industry delivered a solid financial
performance in 2008 despite worldwide economic turmoil, according to
Ernst & Young's 23rd annual report on the biotech industry. 19 May 2009
GE commits US$6bn to healthcare
innovation
GE has announced a US$3 billion budget for the next six years for
healthcare innovation, a further US$2 billion of financing and US$1
billion in related GE technology and content to drive healthcare
information technology and health in rural and underserved areas. 11 May
2009
Phase Forward signs agreement with
Novo Nordisk for use of InForm for clinical trial data capture
The multi-million dollar agreement allows Danish company Novo Nordisk to
use Phase Forward’s InForm electronic data capture product across all
clinical trial phases, from Phases I through IV. 7 May 2009
PerkinElmer becomes exclusive
distributor for ID Biological Systems’ newborn screening sample
collection cards. 7 May 2009
Major Portuguese hospital selects
Sectra to provide PACS
Hospital de São João, one of Portugal’s largest hospitals, has selected
Sectra to provide picture archiving and communications (PACS) products
and services in a multi-year contract. 7 May 2009
St Jude Medical gains EU approval
for remote care system for implantable cardiac devices
St Jude Medical's Merlin.net Patient Care Network (PCN) is a secure,
Internet-based remote care system that gathers and stores data from the
implant procedure, a clinic follow-up visit or from remote follow-up
transmissions of patients with implanted cardiac devices. 7 May
iSOFT wins €600,000 HIS contract in
Italy
IBA Health Group Limited has announced that iSOFT has entered the
Italian market with a €600,000 contract to install its hospital
information system in four hospitals operated by Consorzio Regionale
Servizi Sociali (CRESS), a private healthcare group. 6 May 2009
Philips acquires Canadian minimally
invasive instrument supplier Traxtal
Royal Philips Electronics has announced that it has acquired
Canada-based Traxtal Inc., Traxtal will become part of the Ultrasound
business within the Philips Healthcare sector. 6 May 2009
SCM Microsystems completes merger
with Hirsch Electronics
SCM Microsystems, Inc. based in Ismaning, Germany, has announced that it
has closed its merger with Hirsch Electronics Corp. Hirsch is now a
wholly-owned subsidiary of SCM. 6 May 2009
Gemalto joins SAFE-BioPharma
Association
Gemalto is joining with biopharmaceutical and healthcare industry
leaders to help the industry achieve its common goal of a fully
electronic business environment by 2012. 23 April 2009
Rigel Pharmaceuticals and Proteros
extend research collaboration
The collaboration gives Rigel access to Proteros’ Gallery Structures
enabling Rigel to rapidly deliver high quality protein-ligand structural
information. 23 April 2009
Parabon NanoLabs to use power of grid computing to design novel
macromolecules based on synthetic DNA
Parabon Computation has spun off Parabon NanoLabs to develop nano-scale products based on designer DNA technology.
It will initially focus on developing nano-scale sensors for
therapeutics, diagnostics and other molecular detection systems.
9 April 2009
Cardima surgical ablation probe
receives EU approval
Cardima, Inc. has received CE Mark approval for its Surgical Ablation
Probe with Stabilization Sheath. The system can be used in open-chest
surgery in conjunction with other procedures, or as a thoroscopic
standalone, closed-chest procedure. 9 April 2009
BioAdvance Greenhouse invests
$550,000 in Novira Therapeutics' antiviral drug technology
Novira is focused on the development of novel small-molecule drugs
against medically-important viral targets. 8 April 2009
AtriCure’s cryoablation system receives
US FDA clearance.
AtriCure's disposable cryoablation system, Cryo1, received 510(k) clearance from the US FDA
for the cryosurgical treatment of cardiac arrhythmias. 8 April 2009
Physio-Control receives US
clearance for Lifepak 15 monitor/defibrillator. 8 April 2009
OrSense receives EU approval for
non-invasive haemoglobin and pulse oximetry monitoring system
OrSense Ltd has received a European CE Mark for its NBM-200MP, a
multi-parameter sensor for non-invasive continuous hemoglobin, low
signal oximetry and pulse rate measurements. 8 April 2009
Genedata strengthens TcLand
Expression’s research informatics infrastructure for personalized
medicine. 8 April 2009
AVEO and Biogen Idec in partnership
to develop ErbB3-targeted antibodies. 8 April 2009
Aphios collaborates with VivaCell
Biotechnology España to develop combination therapy for HIV latency.
8 April 2009
FluGen secures exclusive rights to
novel vaccine-delivery technology
Flugen Inc., has secured rights to vaccine-delivery technology being
commercialized by Ratio Inc. The easy-to-use, disposable micro-device
painlessly delivers seasonal and pandemic influenza vaccines. 7 April
2009
Gene Bridges licenses recombineering
technology to Daiichi Sankyo
Heidelberg-based Gene Bridges GmbH, has licenced its Red/ET
recombination technology to Japanese company Daiichi Sankyo. 7
April 2009
Intel and GE form $250m alliance to
develop home healthcare technology
GE and Intel Corporation have entered into an alliance to market and
develop home-based health technologies that will help the elderly live
independently and patients with chronic conditions manage their care at
home. 6 April 2009
German medical technology sector
withstanding economic crisis
Only 4% of companies in the German medical technology sector have
reduced their workforce as a result of the global financial crisis,
according to a survey conducted by the German Medical Technology
Association, BVMed. 27 March 2009
Smart Cells establishes base in Italy
London-based Smart Cells International, the UK's longest-established
cord blood stem cell processing and storage organisation, has
established a base in Milan, Italy, with a joint venture with Laborest,
one of Italy's leading pharmaceutical businesses. 25 March 2009
Systech to integrate serialisation
expertise with Axway’s track and trace system
Axway and Systech International will partner to offer integrated systems
for pharmaceutical supply chain integrity to ensure customer readiness
for upcoming European and Turkish regulatory compliance. 25 March 2009
Domainex in collaboration to develop
novel breast cancer drug targets
Domainex has announced a collaboration on drug-discovery programmes with
the Breakthrough Breast Cancer Research Centre and The UK Institute of
Cancer Research to identify and develop inhibitors of two recently
validated breast cancer targets, tankyrase and IKK-epsilon. 23 March
German healthcare group selects Varian
linear accelerators for radiotherapy
The HELIOS Kliniken Group is acquiring nine linear accelerators from
Varian Medical Systems (NYSE: VAR), the majority of them equipped with
RapidArc technology. The new machines will replace older models and add
capacity that will give more patients access to the most advanced cancer
care. 23 March 2009
Touch Bionics’ founder steps down
Touch Bionics, developer of the world’s first commercially available
bionic hand, has announced that Director of Research and Non Executive
Director, David Gow, was stepping down from the business to concentrate
on his expanding role within NHS Lothian’s SMART Centre in Edinburgh. 17
March 2009
Siemens obtains full rights to the i.s.h.med
hospital information system
Siemens Medical Solutions is taking over all use and exploitation rights to the
software i.s.h.med, a clinical information system integrated with the
SAP healthcare software. The system was jointly developed by the partner
and forerunner companies of Siemens Medical Solutions GSD GmbH and the
Austrian T-Systems. Deutsch
St Jude Medical receives EU approval
for neurostimulation system for chronic angina
St Jude Medical's Genesis neurostimulation system is for managing a form
of chest pain known as chronic angina pectoris, or chronic angina. It
helps to control angina pain by sending mild pulses of electricity from
a device implanted in the torso to nerves located along the spinal cord.
12 March 2009
Dräger receives double design award
for medical devices
Two Dräger products have received the iF product design award in 2009:
The Ponta beam system and the Infinity C700 for IT workstation. The iF
product design award is one of the most important design competitions
worldwide. 12 March 2009
StemCells to acquire drug discovery
technology of Stem Cell Sciences
StemCells, Inc. is to acquire the operating subsidiaries and certain
related assets of Stem Cell Sciences (SCS), a Cambridge, UK-based
company focused on commercializing applications of stem cell
technologies for drug discovery and regenerative medicine research. 10
March 2009
Lab21 acquires Biotec Laboratories
Lab21 Ltd of Cambridge, UK, has announced that it has purchased the
majority shareholding of another UK company Biotec Laboratories Ltd, a
clinical diagnostic company with particular emphasis on infectious
diseases. 10 March 2009
Michelson Diagnostics raises £350K for
clinical trials and growth
The money will be used to support multi-centre clinical trials of its
new hand-held multi-beam optical coherence tomography (OCT) imaging
probe, and also aid international commercial growth. 4 March 2009
Yorkshire attracts major investment in
healthcare technologies
The Yorkshire and Humber region in northeast England has accounted for
nearly 10% of first-round investments in healthcare technology in the
UK, according to figures revealed at the launch of a new Access to
Finance programme for local healthcare technology companies. 2 March
2009
Abbott completes takeover of Advanced
Medical Optics
Abbott has announced that it has completed its acquisition of Advanced
Medical Optics (AMO), which is now a wholly owned subsidiary of Abbott
with the new name Abbott Medical Optics Inc. 2 March 2009
Sciemetric wins major quality control
contract in medical device sector
Sciemetric Instruments, a supplier of manufacturing quality systems has
been named a preferred supplier to one of the world’s largest medical
device manufacturers, cementing its position in a key growth market for
the company. 27 February 2009
APR acquires new drug delivery
nanotechnology for innovative treatment of critical diseases
Swiss company Applied Pharma Research s.a. (APR) has acquired a
nanocoating process for the preparation of new products for the
treatment of several critical diseases. APR is already developing
specific applications in ophthalmology and dermatology. 22 February 2009
Varian receives European approval for
proton therapy system
Proton therapy allows doctors to use higher doses of radiation to
control and manage tumours while significantly reducing damage to
healthy tissue and vital organs. 22 February 2009
Symphogen secures €33m financing to
support clinical development of antibody products
Copenhagen-based Symphogen A/S has announced the closing of €33 million
(approximately US $44 million) financing. The financing will be used to
mature the company’s product pipeline of antibody therapeutics,
particularly within the field of oncology. 16 February 2009
Millipore acquires Guava Technologies
Millipore Corporation (NYSE: MIL), a leading provider of technologies,
tools and services for the global life science industry, has entered
into an agreement to acquire Guava Technologies, a provider of
easy-to-use, bench top cell analysis systems. 16 February 2009
Mirna Therapeutics and UCSF to explore
therapeutic potential of microRNAs
Mirna Therapeutics and the University of California, San Francisco
have entered into a collaboration agreement to evaluate the capacity of
specific microRNAs to reduce or eliminate tumours in mouse models of
cancer. 16 February 2009
Masimo files lawsuit against Philips
for pulse oximetry patent infringement. 16 February 2009
Expression Analysis in partnership
with Complement Genomics to offer genomic services in UK. 16
February 2009
Response Genetics closes UK facility
Response Genetics has announced that it is closing its Edinburgh, UK
facility and increasing the capacity of its genetic testing laboratory
in Los Angeles, USA. 16 February 2009
International collaboration to develop
ultrasound-activated drug-delivery nanoparticles
Nanobiotix, an emerging nanomedicine company has announced that it will
collaborate with the SonoDrugs project consortium to develop new
nanoparticulate drug carriers that can be activated for localized drug
release using focused ultrasound. 10 February 2009
Sysmex in agreement to distribute
AdnaGen cancer diagnostic tests in Europe
Sysmex Europe GmbH and AdnaGen AG have entered into a non-exclusive
European distribution agreement for AdnaGen proprietary CE-certified
diagnostics as well as their research use only (RUO) products. 10
February 2009
EXACT Sciences in strategic
relationship with Genzyme for DNA diagnostics technology
Genzyme has acquired intellectual property assets related to prenatal
and reproductive health and three million shares of EXACT common stock
for $24.5 million. 9 February 2009
FORMA to collaborate with Cubist to
develop novel antibacterial drugs
FORMA Therapeutics has signed a collaboration agreement with Cubist
Pharmaceuticals, Inc. to leverage FORMA’s transformative chemistry
platform to discover novel antibacterial compounds for development by
Cubist. 9 February 2009
IAVI and Algonomics to collaborate on HIV protein design project
The International AIDS Vaccine Initiative (IAVI) and Belgian company
Algonomics have announced a collaboration to develop novel vaccine
candidates capable of controlling HIV infection.
9 February 2009
Tomotherapy radiation treatment
planning software gains FDA clearance
Swedish company RaySearch Laboratories AB and TomoTherapy Inc have
announced that their jointly produced new software solution for the
Tomotherapy Hi-Art linear accelerator has received clearance by the FDA
for market launch in the US. 9 February 2009
Pfizer to acquire Wyeth for $68bn
Pfizer and Wyeth have
entered into a definitive merger agreement under which Pfizer will
acquire Wyeth in a cash-and-stock transaction worth approximately $68
billion. 4 February 2009
Graffinity and Elan in fragment-based
drug-discovery collaboration
Under the terms of the agreement, Graffinity will receive technology
access fees and success payments for the generation of novel small
molecule hits against a number of drug targets. 4 February 2009
Ontario grants Agfa Healthcare
$29.6-million to create jobs for developing radiology software
The award is to help create 100 new jobs and support existing jobs by
supporting Agfa in the development of new software that allows
radiologists to share digital images across a regional network. 31
January 2009
Johnson & Johnson joins Enlight
Biosciences in US$52 million in novel drug discovery initiative
As a partner, Johnson & Johnson will have the opportunity to invest in
the development of strategic technologies that have the potential to
fundamentally transform drug discovery. 31 January 2009
Richter-Helm and Athera
Biotechnologies in partnership to develop recombinant protein for
cardiovascular disease
The partnership will develop and manufacture Athera's novel product for
prevention of plaque rupture and athero-thrombosis through binding of
the protein, Annexin A5, to endothelium. 31 January 2009
Allium Group receives CE Mark for
next-generation prostatic stent
Allium Group has announced that it has been awarded CE mark for its
prostatic stent, enabling commercialization of the system in the
European Union and the countries that recognize the CE Mark. 31 January
2009
Philips collaborates with Bard
Electrophysiology to advance cardiac arrhythmia treatment
Royal Philips Electronics has announced an agreement with Bard
Electrophysiology to co-develop new clinical tools to help
electrophysiologists treat patients suffering from arrhythmias. 31
January 2009
Vivacta achieves ISO13485 for quality
management
Vivacta has announced that it has achieved compliance with ISO13485, an
important step towards the successful commercialisation of its
ultrasensitive point-of-care immunochemistry system. 31 January 2009
Crospon receives CE Mark for EndoFLIP
System
Irish medical device developer Crospon has announced that its EndoFLIP
system has received CE Mark certification from the NSAI (National
Standards Authority of Ireland), the Irish Notified Body, in accordance
with the European Medical Device Directive. 31 January 2009
St Jude's Libra deep brain stimulation
systems for Parkinson’s disease gains EU approval
St Jude Medical has received the European CE Mark approval for its Libra
and LibraXP deep brain stimulation (DBS) systems, the company's first
products in the DBS market. 31 January 2009
e-Therapeutics enters drug discovery
partnership with Cresset BioMolecular Discovery
e-Therapeutics plc (AIM: ETX) has entered into an agreement with
UK-based Cresset BioMolecular Discovery Ltd, a specialist in molecular
field technology. The initial focus of the collaboration will combine
e-Therapeutics’ computational platform with Cresset’s advanced
technology in chemical comparison. 27 January 2009
Morphotek in evaluation agreement with
University Hospital Heidelberg
The evaluation will advance the company's efforts in the discovery and
development of therapeutic antibodies in oncology. 25 January 2009
Michelson Diagnostics singled out as
high-growth company
UK-based Michelson Diagnostics has been singled out as a company with
high growth potential by two leading investor organisations. 25 January
2009
New Venture Partners and Unilever
Ventures invest in personalised weight management system
New Venture Partners LLC, the global venture capital firm dedicated to
corporate technology spinouts, and Unilever Ventures, the early stage
venture arm of Unilever, have jointly invested in MiLife, a company
focused on providing technology solutions for personalised weight
management. 25 January 2009
UK healthcare technology companies
urged to tap into growing Middle East markets
UK Trade & Investment (UKTI) and the Association of British Healthcare
Industries (ABHI) are urging UK healthcare technology businesses to
capitalise on demand in the fast growing Middle East market. 23 January
2009
ICON completes takeover of Beacon
Bioscience
Dublin-based ICON plc has completed the acquisition of the remaining 30%
shareholding of Beacon Bioscience Inc. 22 January 2009
Boston Scientific acquires Labcoat's
stent technology
Boston Scientific Corporation has acquired Labcoat Limited, a privately
held, development-stage drug-eluting stent technology company located in
Galway, Ireland. Terms of the acquisition were not disclosed. 16 January
2009
Sigma-Aldrich acquires Seppro
depletion technology from GenWay Biotech
Sigma-Aldrich has expanded its proteomics offerings with the acquisition
of Seppro affinity depletion technology and a library of 700
avian-derived antibodies from GenWay Biotech, Inc. Seppro depletion
products enable scientists to measure more precisely the expression of
protein biomarkers from a range of mammalian and plant biological
samples. 16 January 2009
ExonHit Therapeutics expands strategic
collaboration with Allergan
ExonHit Therapeutics has announced a reinforcement of its existing drug
discovery collaboration with Allergan Sales. The collaboration includes
antibody discovery within the scope of the research activities and
encompasses revised commercial terms. 16 January 2009
PerkinElmer launches Operetta high
content screening system
PerkinElmer, Inc., has launched its Operetta system, a benchtop
instrument that provides high content screening (HCS) and high content
analysis (HCA) capabilities to drug discovery and cellular science
research laboratories.
Abbott acquires Ibis Biosciences
Abbott has exercised its option to purchase the remaining equity
ownership in Ibis Biosciences, Inc., an Isis subsidiary, for a closing
purchase price of $175 million. 12 January 2009
CMPMedica signs global contract with
iSOFT for drug information decision support tools
CMPMedica's information solution will power iSOFT's suite of
decision-support tools. These tools enable healthcare professionals to
make better informed decisions at the point of care and thus improve
patient outcomes. 9 January 2008
AorTech signs licensing agreement for
medical device components
AorTech International plc has announced a technology license and
material supply agreement with a leading manufacturer of a
life-sustaining circulatory support system. 9 January 2009
Agfa wins contract from Antwerp
University Hospital for cardiovascular system
Antwerp University Hospital, Belgium, has awarded Agfa HealthCare a
contract for its IMPAX Cardiovascular solution. The contract will
provide enterprise-wide access to cardiology patient records to meet the
high volume diagnostic needs. 6 January 2009
Business news: Now
| 2008
| 2007 |
2006 | 2005
To top
|